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1. WNT SIGNALING AN OVERVIEW 
 
 
 
 The gene to which this signaling pathway owes its name was initially characterized as Int-
1, later called Wnt-1, by Nusse et al. in mouse mammary tumours. They showed that this gene 
was frequently activated by retroviral insertion of the mouse mammary tumour virus (MMTV) 
(1). This oncogene is highly conserved throughout evolution and is an orthologue of the 
Drosophila segment polarity gene Wingless (2). The similarity in sequence and function between 
Int-1 and Wingless lead to the re-naming of Int-1 as Wnt-1. 
 The Wingless protein is essential for segmentation in Drosophila. It is a secreted factor 
that influences cell fate of nearby cells in several organs, like in the cuticle and imaginal discs. 
The Drosophila cuticle comprises a repeated pattern of segments, with the anterior part consisting 
of denticles and the posterior part made of naked cuticle (Figure 1A). Mutant flies deficient for the 
Wingless gene product show highly disrupted patterning of the larval cuticle, resulting in a lawn 
of uniform denticles. Many components that have a role in this signal transduction pathway have 
been identified in extensive mutagenesis screens in Drosophila, based on the phenotype of 
disturbed segmental patterning. From these experiments a picture emerged of two types of 
proteins implicated in this cascade. Activating components, comprising proteins that upon 
mutation give rise to flies with a cuticle consisting of a uniform lawn of denticles (Figure 1B), 
include Dishevelled (3), Armadillo (4) and Tcf (5). Negative regulators for the pathway were also 
identified in this way, by virtue of their mutants giving rise to a cuticle lacking denticles (Figure 
1C). Examples of these include Shaggy (6) and Axin (7). 
 
 
 
 
 
Figure 1. Cuticle phenotype of Drosophila mutant flies. 
Depicted are the cuticle phenotypes of wild type (A), and flies mutant for either activating components of the 
Wingless signaling cascade, like Wingless, Dishevelled, Armadillo and Tcf (B), or negative regulators, like Axin and 
Shaggy (C). (This figure was kindly provided by R. Nusse) 
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 From genetic epistasis experiments the order of events in the signaling cascade was 
determined and an initial picture of the Wnt signaling cascade emerged: Wingless activates 
Dishevelled, which in turn inhibits the kinase Shaggy, resulting in activation of Armadillo. 
 The identified Drosophila proteins are conserved throughout evolutions, with orthologs 
present in many species e.g. frogs, mouse and humans. The first vertebrate assay to determine the 
role of a protein in the Wnt signaling cascade came from Xenopus. Ectopic expression of Int-1 in 
Xenopus leads to duplication of the body axis, resulting in a two headed tadpole (8). The sequence 
homology of different components and their effect in the Xenopus double axis assay showed the 
striking conservation between the Drosophila and vertebrate Wnt signaling cascade. Moreover, in 
vertebrates Wnt activates Dishevelled, Dishevelled inactivates GSK-3 (the vertebrate ortholog of 
Shaggy), resulting in activation of β-catenin, the mammalian Armadillo ortholog. 
 For a long period, β-catenin was the most downstream component identified in the Wnt 
signaling pathway. It was known to have a dual function in cell adhesion and in Wnt signaling, 
with separate domains in these different roles. The N-terminus is required for cell-cell adhesion, in 
which β-catenin is a component of the adherens junctions, and the C-terminus is essential for its 
role in Wnt signaling (reviewed in (9)). It only became clear how a Wnt signal can affect the 
downstream genetic program upon the identification of the family of TCF/LEF/Pangolin 
transcription factors as binding partners of β-catenin (10, 5, 11, 12). Many other components have 
now been identified, delineating the Wnt signaling cascade as we now know it (Figure 2). Some of 
the steps in the pathway will be discussed in more detail below. 
 In the absence of Wnt signaling, β-catenin levels are kept low by the activity of a complex 
containing the serine/threonine kinase GSK3-β, the scaffold protein Axin (13, 14, 15) and the 
tumour suppressor protein APC (reviewed in (16)). This so called degradation complex 
phosphorylates β-catenin. The F-box protein β-TRCP recognises phosphorylated β-catenin and 
primes it for destruction by the proteasome (17, 18). Without free β-catenin, Tcfs bind members of 
the Groucho family and actively repress transcription of target genes (19, 20). 
 When a Wnt protein reaches a cell, it is bound by Frizzled and its co-receptor LRP (21, 22, 
23). Accumulation of β-catenin results in its translocation to the nucleus (reviewed in (24, 25)), by 
an as yet unidentified mechanism. In the nucleus, β-catenin associates with transcription factors of 
the TCF family to generate a functional transcription factor complex, resulting in the 
transactivation of target genes, such as c-Myc (26), Tcf-1 (27), and EPHB-2 (122), marking the 
onset of a defined genetic program. 
 
 
 
Chapter 1 
 12 
 
 
Figure 2. A schematic overview of the Wnt signaling pathway 
In the absence of a Wnt signal (left) β-catenin is phosphorylated by GSK3-β, in a complex also containing Axin and 
APC. Upon phosphorylation, β-catenin is primed for ubiquitination and subsequent degradation by the proteasome. In 
the nucleus, Tcf proteins bind Groucho family members and repress target genes. 
When a Wnt protein reaches the cell (right), it associates with the transmembrane receptors Frizzled and LRP. The 
destruction complex of GSK3-β, APC and Axin is subsequently inactivated via Dishevelled, resulting in the 
accumulation of β-catenin and its translocation to the nucleus (25). Here, β-catenin associates with transcription 
factors of the TCF family to generate a functional transcription factor complex, resulting in transactivation of target 
genes. 
 
 
 
 
2. WNT SIGNALING AT THE CELL MEMBRANE 
 
 
 
 The receptors for Wnt proteins, Frizzleds have also been implicated in other signaling 
pathways (figure 3). Initially they were identified because of their role in hair polarity in the 
Drosophila wing (29). A number of genes have been identified in screens for flies with mutant 
polarisation of cuticle structures, like strabismus, RhoA, Frizzled and Dishevelled. These and 
many other genes make up the pathway determining the polarity of hairs, bristle, ommatidia etc, 
referred to as the planar polarity pathway. This is also called the non-canonical Wnt pathway to 
make the distinction from the canonical pathway, which makes use of the same Wnt, Frizzled and 
Dishevelled proteins to mediate up-regulation of β-catenin and Tcf activation. 
 In Xenopus, Wnts and Frizzleds have been shown to be implicated in yet another signaling 
route, the Wnt/Ca2+ pathway (reviewed in (30)). Some Wnts stimulate intracellular Ca2+ release 
and activate two kinases, CamKII and PKC. 
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Figure 3. Frizzled receptors are implicated in different signaling cascades. 
Frizzled can signal via Dishevelled to β-catenin and Tcf, using the canonical pathway, and to RhoA using the planar 
polarity pathway. Frizzled can signal to the Ca2+ pathway independent of Dishevelled. 
 
 
 
Regulation of the transduction of a Wnt signal to intracellular responses occurs at the cell 
membrane. A number of mechanisms are known to fine-tune this first step in the Wnt signaling 
cascade (Figure 4). Several secreted molecules have been identified, which interfere with the 
association of Wnts with their receptors. Frizbees (FRZB) were identified in Xenopus, which are 
secreted proteins that consist of the ligand binding domain of Frizzled receptors (31, 32, 33). 
These FRZBs compete for binding to Wnt proteins, thereby preventing Wnt Frizzled interaction. 
A structurally unrelated Wnt inhibitory factor (WIF) also encodes a secreted protein able to bind 
to Wnts directly and thereby inhibit signaling (34). Additionally, the protein Cerberus was shown 
to be a pluripotent antagonist for several growth factors; it can inhibit Wnt BMP and nodal 
signaling (35). 
 The mechanism governing how the distinction is made between canonical and non 
canonical signal transduction is not yet entirely clear. One way to selectively signal to one route is 
conferred by specific types of Wnt proteins binding to specific Frizzleds. Wnt proteins are 
classified as two groups based on their ability to signal through either of the pathways. Wnts such 
as Wnt-1, -3A and 8A, which induce a secondary axis in Xenopus embryos following ectopic 
expression and posses the ability to transform an epithelial cell line are classified to the canonical 
pathway. Wnt proteins such as Wnt-5a, -4 and –11, which can reduce cell adhesion and induce 
cell movement in Xenopus embryos, are assigned as signaling through the non-canonical pathways 
of RhoA or Ca2+. 
 With the recent identification of the Frizzled co-receptor LRP (23, 22, 21) and its 
inhibitory complex Dickkopf and Kremen, it has become more clear how the planar polarity and 
canonical Wnt signaling cascade are intertwined. A Wnt protein requires binding to both Frizzled 
and its co-receptor LRP to transduce the signal to the canonical pathway. This can be inhibited by 
Chapter 1 
 14 
the Dickkopf protein, and its receptor Kremen (36, 37). Dickkopf binds simultaneously to Kremen 
and LRP, resulting in internalisation of this ternary complex (38). LRP is thus depleted from the 
cell membrane and the Wnt-Frizzled complex can no longer signal to the canonical pathway. 
Signaling to the non-canonical pathway is not, however, inhibited by Dickkopf and Kremen. 
 
 
Figure 4. Wnt signaling at the membrane. 
A. A Wnt ligand binds its receptors Fz and LRP, initiating signaling through both canonical and non-canonical 
pathways. 
B. Dickkopf prevents LRP from associating with Wnt and Fz, ensuring that only signaling through the planar polarity 
pathway can occur. 
C. Soluble factors like FZB and WIF, bind Wnt directly, inhibiting binding to the Fz receptor, and thereby blocking 
any signaling through this receptor. 
 
 
 
 
 
3.  THE DESTRUCTION COMPLEX AND NUCLEAR TRANSPORT 
 
 
 In the normal cell, β-catenin is mainly present in adherens junctions, where it mediated cell 
adhesion as a component of the E-cadherin complex. Any free β-catenin in the cytosol will be 
immediately degraded by the proteasome in the cytoplasm. This degradation is initiated by the 
phosphorylation of β-catenin which occurs in a multiprotein complex of the serine/threonine 
kinase GSK-3β, the tumour suppressor APC, the scaffold protein Axin and Casein Kinase I (CKI). 
β-catenin contains four highly conserved phosphorylation sites, S33, S37, T41 and S45. 
Phosphorylation of these sites is a two step process. Initially CKI, or 'priming kinase', 
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phosphorylates S45, which triggers phosphorylation of the other sites by GSK3β (39, 40). 
Phosphorylated S33 and S37 are the recognition site for β-TRCP, which ubiquitinates β-catenin 
and targets it for destruction by the proteasome (17, 18). 
 The function of APC in this complex is not yet entirely clear. The protein was first 
identified as the gene defective in familial adenomatous polyposis (FAP), a dominantly inherited 
disease that predisposes to colorectal tumours (41, 42). It has become clear that >80 % of all colon 
cancers have mutations in this gene (43, 44). The APC mutations found in the tumours are usually 
located in a central region of the gene, referred to as the mutation cluster region (MCR), and cause 
truncation of the protein (Figure 5). Apparently, there is a strong selection against domains 
downstream of the MCR, and a positive selection for upstream sequences, that may be implicated 
in functions essential for cell survival. Wnt signaling and cancer will be discussed in more detail 
later in this report. APC is implicated in a large variety of cellular processes such as regulation of 
cell proliferation, cell adhesion, cell migration and chromosome stability (reviewed in (16) and 
(45)). Many of these functions have been assigned following identification of interacting proteins. 
Only the role of APC in β-catenin regulation will be described in detail here. 
 
 
 
 
 
Figure 5. Schematic representation of the APC protein. 
The APC protein contains many structural domains. Here are only indicated the mutation cluster region, the domains 
for nuclear import (NLS) export (NES) and the domains implicated in interaction with β-catenin and Axin. 
 
 
 
 APC is a 300 kDa highly conserved protein that is localised both in the cytoplasm and 
nucleus. Several functional domains have been identified in this protein (Figure 5). The N-
terminal part of the protein contains an oligomerization domain, two nuclear export signals and 
armadillo repeats. The central region of the protein contains the β-catenin (46, 47) and Axin (48, 
13, 49) interaction domains and another two nuclear export signals (50). The c-terminal part of the 
protein contains a nuclear localization domain and a basic domain. Analysis of mouse models with 
different truncations of the APC gene indicated that the Axin interaction domains of APC, but not 
the more C-terminal domains, were essential for APC function as tumour suppressor. This implies 
that the down-regulation of β-catenin by APC is essential for tumour suppression (6). This is also 
indicated by mutations found in several types of tumours in β-catenin phosphorylation sites 
(reviewed by (51)). 
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 APC has also been shown to shuttle between the nucleus and the cytoplasm (52, 53, 50). 
APC shifts from cytoplasmic to nuclear localization upon treatment with leptomycine B (LMB), a 
CRM-1 specific nuclear export inhibitor. Also β-catenin localization can be regulated by LMB, 
but in an APC dependent manner. Wild-type APC can restore β-catenin degradation in an APC 
mutant cell line, but this is dependent on functional NES sequences. This data suggests that wild 
type APC controls β-catenin levels by a combination of nuclear export and subsequent 
cytoplasmic degradation. 
 
 
 
 
 
4. TCF TRANSCRIPTION FACTORS 
 
 
 
The TCF/LEF transcription factors are the most downstream components of the Wnt 
signaling cascade. The mammalian genome harbours 4 family members, TCF-1, LEF, TCF-3 and 
TCF-4, which share homology in their DNA binding domain with members of the HMG box 
transcription factor family (Figure 6). TCFs bind their target DNA sequences within gene 
promotors via the HMG box DNA binding domain. The TCF consensus recognition sequence is 
remarkably conserved, and comprises AGATCAAAGGG (54, 55, 56). The HMG box does not 
only mediate DNA sequence recognition, but also induces a dramatic bend in the DNA (57, 58). 
By doing so, HMG boxes may coordinate the binding of other transcription factors (59, 60, 61). 
Because of this bending ability and the observation that TCF factors cannot directly activate 
transcription in reporter assays, it has been proposed that TCF/LEF family members primarily 
serve an architectural function. LEF-1 appears unique in that it contains a context-dependent 
activation domain (CAD) (62), which can activate transcription in the presence of the co-activator 
ALY (51). The other TCF family members do not appear to contain a CAD domain (63). 
The TCF proteins show extensive alternative splicing, leading to a multitude of TCF 
proteins in the mammalian system. Splice variants have been identified for Tcf-1, Lef and Tcf-4. 
The Tcf-1 gene has two different promotors, four alternative exons and two splice acceptor sites in 
the last exon, giving rise to proteins with and without the n-terminal β-catenin interaction domain, 
with and without a central small exon and with a short or long c-terminal tail (64, 63). For Tcf-4 
three c-terminal alternative splice variants were identified (65) and the LEF gene also contains 
three alternatively spliced exons (66). 
In general, TCF proteins do not function as classical transcription factors, in that DNA 
binding alone is not sufficient to cause transcriptional activation. Promotor activation is only 
achieved after complex formation of TCF with β-catenin to generate a functional bi-partite 
transcription factor. Within this complex TCF provides the DNA binding moiety and β-catenin the 
transcription activation domain (reviewed in (67)). 
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Figure 6. Structure of TCF family members 
The mammalian genome harbours four TCF family members. They all contain three distinct conserved domains: a N-
terminal β-catenin interaction domain, a HMG box DNA binding domain and a Groucho interaction domain. 
 
 
 
 
4.1 TCF AS A TRANSCRIPTIONAL ACTIVATOR 
 
 
Following association of TCF and β-catenin to form a bipartite transcription factor, target 
gene promotors are activated. Although the mechanism is not fully elucidated, some recent 
progress has been made to describe the mechanisms involved in this process. β-catenin is 
composed of several domains. Its N terminal domain contains putative GSK3-β sites, regulating 
its priming for ubiquitination (68, 69). The central domain consists of 12 armadillo repeats that 
mediate binding to α-catenin, E-cadherin, APC, Axin and TCF. The C-terminus of β-catenin 
contains a potent transactivation domain (reviewed in (70)). 
Several mechanisms are described through which β-catenin can stimulate transcription. β-
catenin may directly interact with TATA binding protein (TBP) (71), or indirectly via Pontin52 
(72). This would provide a direct interaction between TCF-β-catenin and the basal transcription 
machinery, resulting in transactivation of target genes. Another mechanism through which β-
catenin stimulates transcription is through interaction with the histone acetyl transferase CBP 
(CREB binding protein), that binds to a region C-terminal of the armadillo repeat 10. In Xenopus 
embryos β-catenin synergises with CBP to stimulate transactivation of the target genes Siamois 
and Xnr3 (73, 74, 75). This transactivation is sensitive to E1A, an antagonist of CBP function. 
Through the interaction with the β-catenin-TCF complex, CBP is tethered to the DNA and may 
locally acetylate nucleosomal histones. This acetylation will result in a more accessible or ‘open’ 
conformation of the chromatin. This conformation might promote binding of other transcription 
factors and allow the general transcription machinery to gain access to the promotor to activate 
transcription (reviewed (76, 77)). 
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Several lines of evidence, however, indicate that there are also CBP-independent 
mechanisms through which β-catenin can mediate transactivation. A β-catenin mutant lacking the 
CBP binding domain still had residual transactivation activity correlating well with the results of a 
previous study, which demonstrated the presence of additional transactivation elements in the N-
terminus of β-catenin (5). Moreover, the cooperative effect of CBP on β-catenin-mediated 
transactivation is only present for a subset of TCF target genes (74). A recent study has shown that 
β-catenin also interacts functionally with Brg-1, a core component of the SWI/SNF chromatin 
remodelling complex (78). This SWI/SNF complex has been shown to participate in the 
displacement of histone octamers from DNA fragments (79) and to promote the sliding of histone 
octamers along the DNA (80). In this way, the SWI/SNF complex is thought to participate in the 
formation of regions with altered nucleosomes at the promotor of specific genes. This could then 
increase the accessibility of the DNA for other transcriptional regulators, resulting in more 
efficient transactivation of target genes. The enhancing effects of CBP or Brg-1 on β-catenin 
mediated transactivation are, however limited, on average inducing an increase of only 2-3 fold. 
This indicates that it is likely that all these factors are acting in concert to achieve efficient target 
gene activation. 
On the other hand, in Drosophila was shown that over-expression of another SWI/SNF 
component, Osa, results in repression of the Wingless target genes Dpp and Distal-less (81). 
Moreover, loss of Osa function induces ectopic expression of these Wg target genes. This 
indicates that chromatin remodelling is also involved in negative regulation of Wingless target 
genes. Clearly, multiple determinants are affecting the final outcome of β-catenin-SWI/SNF 
interaction on Wg/Wnt target genes and further research is needed to elucidate this. 
 
 
 
 
4.2. TCF AS A TRANSCRIPTIONAL REPRESSOR 
 
 
 
4.2.1. ASSOCIATION WITH CO-REPRESSORS 
 
Experiments in Drosophila and Xenopus have shown that TCF does not only function as a 
transcriptional activator, but that it can also actively repress Wingless target genes. This was for 
instance shown for the expression of Ubx in the visceral mesoderm of the fly embryo. Upon 
mutation of TCF sites in the Ubx enhancer it was shown that Ubx expression was decreased near 
the Wingless source, but enhanced in cells further away from the source (82). This effect was also 
reported for Dpp (83) and the Xenopus Siamois gene (84). Apparently, loss of TCF mediated 
regulation can result in increased target gene expression, implying that TCF can also function as a 
transcriptional repressor. Several other observations have confirmed that TCF has this dual 
function (reviewed in (85)). On one side of the balance, TCF will transactivate transcription when 
activated by a Wnt signal, following its association with β-catenin. On the other side, however, it 
can associate with several different transcriptional co-repressors, resulting in inhibition of target 
gene expression in the absence of Wnt signaling. 
 
An introduction to the WNT signaling cascade 
 19
Groucho 
Drosophila Groucho is the founding member of an evolutionary conserved family of 
transcriptional co-repressors (reviewed in (86)). The murine and human genomes harbour four 
full-length homologues of Groucho in addition to a gene that encodes a truncated Groucho 
protein, comprising only the two amino terminal domains. The human Groucho homologues are 
termed TLE-1, -2, -3, -4 (for Transducin- Like Enhancer of Split) and the truncated variant is 
named hAES (for Amino terminal Enhancer of Split). The homologous mouse Groucho family 
consists of the Groucho-related genes Grg-1, -2, -3, and -4 and the Grg-5 gene, which encodes a 
shorter variant (Figure 7). 
The Grg/TLE proteins contain 5 protein domains: an amino terminal Q (Glutamine rich) 
domain, followed by a GP (glycine/proline rich) domain, a CCN domain (containing putative 
casein kinase II/cdc2 phosphorylation sites and a nuclear localization signal), an SP (serine/proline 
rich) domain and four WD40 repeats (protein interaction domain). Of these, the Q and WD40 
domain sequences are most highly conserved. Groucho-related proteins have been described to 
tetramerize through a leucine zipper-like structure in the amino-terminal Q domain (87). 
 
 
 
 
Figure 7. Domain structure of Groucho related proteins 
The family of Groucho-related-genes in the mammalian genome consists of four full length homologues of Groucho, 
Grg-1, -2, -3, and -4 and a gene that encodes a truncated Groucho protein, Grg-5. The Grg proteins 1-4 contain five 
protein domains: an amino-terminal Q (glutamine-rich) domain, followed by a GP (Glycine/proline rich domain), a 
CCN domain (containing a putative casein kinase phosphorylation sites and a nuclear localization signal), a SP 
(serine/proline-rich) domain and four WD40 repeats. Grg-5 only contains the two amino-terminal domains, the Q and 
the GP domains. 
 
 
 
Groucho proteins function as co-repressors for a multitude of DNA binding transcription 
factors of distinct families. Some of these transcription factors, such as Hairy (88), HES (89) and 
Blimp-1 (90), specifically act to repress target gene expression, a function that requires their 
interaction with Groucho. Others, like Runt (91) and Dorsal (92) are activators and convert to 
repressors upon association with Groucho-related proteins. 
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The Drosophila histone deacetylase Rpd3 has been shown to interact with Groucho (93). 
Recruitment of Rpd3 to the promotor of target genes promotes modulation of the local chromatin 
structure. By mechanisms that are not yet fully understood, this appears to result in a more 
compact chromatin structure that is associated with a repressed transcriptional state. Grg-5 cannot 
bind RPD3, which could explain the lack of repression observed with this protein. Grg-5 does, 
however, interact with other Grgs and may in this way decrease the amount of HDAC present in 
the Grg tetramer, thereby lowering the net repressive effect (94). 
Histone deacetylation by RPD3/HDAC is likely to be the predominant mechanism through 
which Groucho-related proteins exert their function, although some data indicate that an additional 
mechanism of repression may exist (88, 93, 93). When Groucho-mediated repression is assayed in 
the presence of the HDAC inhibitor TSA (Trichostatin A) some residual repression activity 
remains. When the histone deacetylase RPD3 in Drosophila is mutated, only a mild phenotype is 
observed (95). These studies suggest that HDAC is an important, but not the sole, mediator of 
transcriptional repression. Further study of the mechanism of Groucho-mediated repression will 
undoubtedly address these questions in the future. 
Several groups have reported that TCFs interact with members of the Groucho family of 
transcriptional co-repressors (19, 20, 96). We found in a yeast two hybrid assay that TCF can 
interact with members of the Groucho family of transcriptional repressors. Using a synthetic 
reporter construct containing TCF binding sites that can be activated by TCF/β−catenin 
complexes, mammalian Groucho family members were demonstrated to repress this TCF-
mediated transactivation. When Grg is injected into Xenopus embryos, it represses endogenous 
target genes such as Xnr3 and Siamois. Another study showed that LEF interacts with TLE-1 and 
inhibits LEF-β-catenin mediated transactivation (96). It was demonstrated that the activity of the T 
cell receptor (TCR) enhancer α, which contains functional LEF and AML binding sites, can be 
inhibited by TLE1. Independently, genetic evidence was obtained in Drosophila confirming a 
functional interaction between Groucho and dTcf (20). Reduction of dTcf activity, suppresses 
wingless and armadillo mutant phenotypes, resulting in de-repression of Wingless responsive 
genes, like engrailed. This indicated a repressive role of dTcf when the Wingless signaling 
pathway is not active. This repression was shown to be Groucho-dependent since mutations in the 
Drosophila Groucho gene also suppress wingless and armadillo phenotypes. 
In contrast to the long Grg variants, Grg-5 functions as a de-repressor for TCF, alleviating 
endogenous Grg mediated repression both in the described reporter assay, as well as in vivo in 
Xenopus injection experiments (19). Every mammalian TCF family member can functionally 
interact with each of the five Grg proteins (94). 
Remarkably, it should be noted that expression of splice variants of TCF proteins lacking 
the β-catenin interaction domain, would result in the presence of a 'repressor' TCF, since these 
proteins can still interact with the ubiquitously expressed Groucho proteins. 
 
 
C-terminal binding protein 
Another study addressing the repressive function of XTcf-3 in Xenopus embryos identified 
the transcriptional co-repressor CtBP as an interaction partner for TCF (97). Two consensus 
motifs for interaction with CtBP, PXDLSX(K/R), are present in the C-terminus of XTcf-3. These 
domains are indeed required for repression mediated by the C-terminal domain of XTcf-3. The 
CtBP interaction motifs are present in TCF-3 and the alternative splice-isoform TCF-4E, but not 
in the other TCF family members. In Drosophila, CtBP mediates short-range repression through a 
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number of unrelated transcription factors, acting over distances of approximately 100 bp (98). In 
contrast, the co-repressor Groucho is classified as a long-range repressor, capable of silencing 
transcription over long distances of approximately 1 kilobase pair (99). Groucho also differs from 
CtBp in its sensitivity to the histone deacetylase inhibitor, TSA. CtBP is not sensitive to the drug, 
whereas Groucho is sensitive to TSA (100). 
 
 
4.2.2. ACETYLATION OF TCF 
 
The histone acetylase dCBP was shown to directly interact with TCF in Drosophila (101), 
resulting in acetylation of a conserved lysine in the β-catenin-binding domain of TCF. This 
acetylation interferes with its binding to β-catenin. dCBP mutants show mild overactivation of 
Wingless targets genes. This activity of dCBP primarily antagonises Wnt signaling in cells that are 
weakly stimulated. Thus, CBP can apparently play a dual role. On one hand it can activate 
transcription by binding to β-catenin, acetylating nucleosomes and opening the chromatin. But 
CBP can also acetylate TCF, reducing its affinity for β-catenin and resulting in a decrease of 
transcriptional activation. The acetylation of TCF by CBP has so far only been described in 
Drosophila. Therefore, it is not known if this is a general function of CBP or whether this is 
specific for Drosophila. 
 
 
 
 
 
5. WNT SIGNALING IN CELL FATE AND CARCINOGENESIS 
 
 
 
Wnt signaling and cell fate. 
 
 Wnt signaling results in the transcriptional stimulation of genes controlling many 
differentiation events in development, both during embryogenesis and adult life. A broad variety 
of processes are regulated by Wnt signaling as was concluded from the expression pattern of the 
different components of the cascade and the phenotype of mice or flies when these proteins are 
mutated. For example Wnt signaling in Drosophila is implicated in the embryonic segmentation 
process and in development of the eye and limbs (reviewed in (102)). In mouse development, Wnt 
signaling was shown to be involved in development of hair follicles (103, 104), thymocyte 
differentiation (105) and gut development (106). 
 The role of Wnt signaling in the development of the intestine has been studied in great 
detail. The mammalian intestine is made up of crypts, the proliferative unit containing stem cells, 
and villi, consisting of migrating and terminally differentiating cells, that will be shed into the 
lumen in a process taking no longer than two to three days. The stem cells in the crypts produce a 
population of highly proliferative cells that are rapidly renewed and migrate up the crypt-villus 
axis. During their migration they differentiate to different cell lineages, namely goblet, 
enteroendocrine and absorptive cells. TCF-4 is the most prominent expressed TCF family member 
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in the intestinal epithelium (107). Targeted disruption of this gene in mice results in loss of the 
proliferative compartment of the intestine during embryonic development (51). The neonatal 
epithelium is composed of differentiated villus cells, resulting in death of the mice shortly after 
birth. This indicates that Tcf-4 controls the genetic program maintaining the crypt stem cells of the 
intestine (106). 
 There are several lines of evidence for tissue-specific responses of the different Tcf/Lef 
proteins during development. In the intestinal epithelium also Tcf-1 is also expressed, 
predominantly as a dominant-negative form lacking the β-catenin interaction domain (27). Genetic 
evidence suggests that Tcf-1 acts as an antagonist of Tcf-4 (27). Also the skin epithelium is 
derived from multipotent stem cells that differentiate into different lineages, the epidermis, 
sebaceous gland and hair follicle. Lef and Tcf-3 were shown to control these differentiation 
lineages (108). Lef requires stabilized β-catenin to express the specific genes and control hair 
differentiation, whereas Tcf-3 can act independently of β-catenin interaction, to suppress 
epidermal differentiation and promotes follicle outer root sheat and multipotent stem cell 
compartments (108). Additionally it was shown in Xenopus was shown that Tcf proteins have 
different, specific functions during embryonic development. Wnt signaling in very early embryos 
leads to a dorsalizing response, which establishes the endogenous dorsal axis. Only a few hours 
later in development, almost the opposite happens: Xwnt-8 functions to pattern the embryonic 
mesoderm by promoting ventral and lateral mesoderm (109). XTcf3 is required for establishment 
of the dorsal body axis by maternally encoded Wnt signaling components, whereas XLef is 
required for dorsoventral patterning of the mesoderm by Xwnt-8 signaling after onset of zygotic 
transcription, a process that is independent of XTcf3 (110). 
 Additionally, specific functions are being attributed to different splice variants of Tcf 
family members. Initially the difference in function of the full length Tcf family members and the 
variants lacking the N-terminal β-catenin interaction domain, was demonstrated, showing that the 
short variants were unable to transactivate transcription, whereas the long versions can (10). 
Recently, also different functions were assigned to the Tcf splice variants with different C-
terminal domains, the longer E variant and shorter B variant. The Lef gene has been shown to be 
aberrantly activated in colon cancer and the promoter of this gene is activated by Tcf-β-catenin 
complexes in transient transfection assays (111). This promoter was selectively activated by the 
isoforms with the C-terminal ‘E’ tail, but not with the ‘B’ tail. The CRARF box in the E-tail is 
essential for this specific activity (112). Correspondingly, the Cdx-1 gene was found to be 
activated by Tcf-4E, but not by Lef, lacking the N-terminus (113). 
 
 
 
Wnt signaling and carcinogenesis 
 
 APC was initially identified as a tumour suppressor gene implicated in colorectal cancer, 
both in hereditary disease and in sporadic tumours (41, 42, 114). The observation that APC binds 
β-catenin was the first link between Wnt signaling and carcinogenesis (47, 46). Mutations in APC 
have been identified in more than 80% of primary colon carcinomas and colon carcinoma cell 
lines. These mutations result in a truncated version of the APC protein, which can no longer bind 
Axin, disrupting the destruction complex. β-catenin is no longer down regulated resulting in 
aberrant activation of target genes. Colon cell lines with mutated APC contain a β-catenin-TCF-4 
complex, which is constitutively active, as measured by a TCF reporter gene (107). However, also 
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colon carcinoma cell lines were analysed that do not have mutations in the APC gene, but still 
display activated TCF-β-catenin signaling. In these cell lines mutations were found in the 
phosphorylation site of β-catenin, rendering it insensitive to phosphorylation and subsequent 
degradation and thereby stabilizing the protein (115). Mutations in Axin2 have also been 
identified in colon carcinoma cell lines resulting in aberrant TCF-β-catenin activation (116). These 
data indicate that constitutive activation of TCF target genes, caused by loss of function of the 
destruction complex, may be a crucial event in transformation of colonic epithelium. Deregulation 
of β-catenin activation is known to be implicated in a large number of other malignancies, such as 
melanoma (117), hepatocellular carcinoma (118, 119), ovarian cancer (120), endometrial cancer 
(119) and pilomatricoma (121). 
 Mutational activation of Wnt signaling in tumourigenesis implied that inappropriate 
activation of the TCF-β-catenin complex would result in the aberrant activation of a genetic 
program leading to carcinogenesis. The relationship between the aberrantly stimulated program in 
colorectal cancer and the physiological program as active during the development of the colon has 
been studied in more detail by Van de Wetering et al (122). Colon cancer cell lines with activated 
TCF-β-catenin complexes were stably transfected with an inducible dominant negative version of 
TCF-4 (DN Tcf-4). Upon induction, endogenous β-catenin-TCF complex were inhibited as was 
shown by TCF reporter assay. Induction of the dominant negative TCF also resulted in a G1 cell 
cycle arrest and cell proliferation was halted. By DNA array analysis it was determined which 
genes were affected upon blocking the endogenous active TCF-β-catenin complex. Two different 
sets of genes were identified. Several genes were down regulated upon induction of DN TCF-4, 
including CD44, c-Myc, BMP4, EPHB-2, -3 and ETS. A group of genes was up regulated upon 
blocking TCF-β-catenin signaling, many of which represented differentiation markers of the 
mucosecretory or absorbtive intestinal cells, like carbonic anhydrase and fatty acid binding 
protein. The induction of several of the identified genes was confirmed by Northern blotting and 
expression patterns were determined in normal common and early neoplastic lesions. All tested 
genes that were down regulated in the array were expressed in early neoplastic lesions. This 
indicates that the constitutive activity of TCF-4 in APC-deficient human epithelial cells may 
contribute to their malignant transformation. Moreover, these same genes were also up regulated 
specifically in the proliferative compartment of normal colon crypts. A complementary expression 
pattern was observed for the genes that were up regulated in the array as they were expressed in 
the top of the villus, in the differentiated compartment. Thus, the changes in gene expression 
induced by blocking TCF-β-catenin activity in colon carcinoma cell lines reflects the 
physiological differentiation of crypt progenitor cells (Figure 8). 
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Figure 8. Wnt signaling regulates proliferation and differentiation in the intestine. 
The bottom third of the colon crypt contains the proliferative cells. Here active Wnt signaling takes place and Tcf-β-
catenin target genes are expressed. As the cells migrate up the crypt-villus axis, Tcf-β-catenin activity is down 
regulated, resulting in cell cycle arrest and differentiation. Upon APC or β-catenin mutation, cells become subject to 
active Tcf-β-catenin signaling and take on a crypt-like undifferentiated phenotype. 
 
 
 Of course many questions remain, such as how the border between differentiated cells and 
proliferative cells is achieved and which mechanism ensures differentiated cell migrating only in 
one direction. This has been addressed by Battle et al., where the role of the Tcf-β-catenin target 
genes of the Ephrin receptors family and their ligands are studied in more detail (123). These 
proteins have been implicated in guidance and sorting of different cell types (reviewed in (124)). 
Interaction between Eph receptors and Ephrin ligands involves direct cell to cell contact and 
frequently results in repulsion. The EPH receptors B2 and B3 and their ligand Ephrin B1 have 
been identified as targets in the array experiment, but with inverse effects. The EPH receptors are 
down regulated upon inhibition of Tcf-β-catenin signaling, whereas the Ephrin ligand is up 
regulated upon inhibition of Tcf-β-catenin, indicative of this ligands being an indirect target. 
Expression of the Ephrin receptors was essential for the correct positioning of the epithelial cells 
along the crypt villus axis, as was shown in EphB2 and B3 knock out mice. Ephrins ligands and 
EphB receptors show a graded expression pattern in the crypts of the small intestine. EphB 
receptor expression is highest in the bottom of the small intestine crypts and Ephrin ligand 
expression peaks at the surface epithelium. This inverse gradient could be a mechanism in which 
it is ensured that the proliferative cells are sorted away from the differentiated cells. 
Additional questions still remaining are: how do stem cells obtain and maintain their 
phenotype? Where does the activating Wnt signal come from? Is it produced in an autocrine 
fashion by the stem cells or by mesenchymal cells? Moreover, it would be interesting to see if this 
role for Wnt signaling in regulating proliferation and differentiation also occurs in other 
differentiation processes of other adult tissues, including breast development and the continuous 
differentiation within the hematopoetic system. Future research is required to shed more light on 
these intriguing questions. 
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Abstract 
 
 
 
Tcf/Lef family transcription factors are the downstream effectors of the Wingless/Wnt signal 
transduction pathway. Upon Wingless/Wnt signaling, β-catenin translocates to the nucleus, 
interacts with Tcf (1, 2, 3) and thus activates transcription of target genes (4, 5). Tcf factors also 
interact with members of the Groucho (Grg/TLE) family of transcriptional co-repressors (6). We 
have now tested all known mammalian Groucho family members for their ability to interact 
specifically with individual Tcf/Lef family members. Transcriptional activation by any Tcf could 
be repressed by Grg-1, Grg-2/TLE-2, Grg-3 and Grg-4 in a reporter assay. Specific interactions 
between Tcf and Grg proteins may be achieved in vivo by tissue or cell type limited expression. 
To address this, we determined the expression of all Tcf and Grg/TLE family members in a panel 
of cell lines. Within any cell line, several Tcfs and TLEs are co-expressed. Thus, redundancy in 
Tcf/Grg interactions appears to be the rule. The "long" Groucho family members containing 5 
domains are repressors of Tcf mediated transactivation, whereas Grg-5 which only contains the 
first two domains acts as a de-repressor. As previously shown for Drosophila Groucho, we show 
that long Grg proteins interact with histone deacetylase-1. Although Grg-5 contains the GP 
homology domain that in long Grg proteins mediates HDAC binding, Grg-5 fails to bind this co-
repressor, explaining how it can de-repress transcription. 
 
 
 
 
 
Introduction 
 
 
 
Recent studies have demonstrated that members of the Tcf/Lef family of HMG box 
transcription factors are important downstream effectors of the Wnt/Wingless signaling cascade in 
mammalian, Xenopus, Drosophila and C.elegans development (7). In the absence of a Wnt signal, 
β-catenin associates with Axin, APC and GSK-3β in the cytoplasm (8, 9, 10). In this complex β-
catenin is phosphorylated by GSK-3β,  resulting in ubiquitination and degradation of β-catenin by 
the proteasome pathway (11, 12). Wnt signaling results in inhibition of GSK-3β, leading to the 
accumulation of β-catenin in the cytoplasm and its translocation to the nucleus. Association of β-
catenin with Tcf in the nucleus leads to the formation of a bipartite transcription factor activating 
target gene expression, such as cyclin D1 (5), Tcf-1 (13) and PPARδ (14). 
Experiments in Drosophila and Xenopus indicated that Tcf molecules could also function 
as transcriptional repressors in the absence of a Wnt/Wg signal (15, 16, 17, 18). Several recent 
studies have proposed a molecular basis for this phenomenon. Tcf can associate with a number of 
different transcriptional co-repressors. Binding of Tcf with CBP (19) or CtBP (20) can lead to 
repression of the Wnt/Wingless response. We and others have shown that the co-repressor 
Groucho and its vertebrate homologs can bind to Tcf. The association of Tcf and Groucho results 
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in repression of Tcf targets both in the context of synthetic promoters and of endogenous genes 
(21, 22, 6). 
The vertebrate Tcf family of transcription factors consists of four members Tcf-1, Lef-1, 
Tcf-3 and Tcf-4 (Figure 1A). Studies have indicated that Tcf-1 is largely expressed in cells of the 
T cell lineage (23). Inactivation of the Tcf-1 gene by homologous recombination results in mice 
with an incomplete block in T cell development (24). Lef is expressed in pre-B and T cells in adult 
mice, and mainly in the neural crest, mesencephalon, tooth germs and whisker follicles during 
embryogenesis. Lef-1 deficient mice die shortly after birth and lack teeth, mammary glands, 
whiskers and hair but show no defects in lymphoid cell populations (25). T cell development in 
mice lacking both Tcf-1 and Lef-1 is completely arrested and impaired at an earlier stage than in 
mice lacking only Tcf-1, revealing that Tcf-1 and Lef-1 are partially redundant in the regulation of 
T cell development (26). Tcf-3 is expressed in stomach epithelium, hair follicles and keratinocytes 
of the skin (27). Tcf-4 expression occurs much later in embryogenesis than Tcf-1, Lef-1 or Tcf-3 
and is most highly expressed in the midbrain and in intestinal and mammary epithelium. Tcf-4 
exhibits a highly restricted expression pattern in the epithelium of the developing gut (27, 28). 
Continued expression of Tcf-4 expression at this site is essential for the maintenance of the 
progenitor compartment of gut epithelium, as indicated in Tcf-4 deficient mice by the abnormal 
development of their small intestines (29). Constitutively active Tcf-4-β-catenin complexes are 
found in the nuclei of colon carcinoma cells with mutations in APC or β-catenin (30). Presumably 
this results in the uncontrolled activation of Tcf target genes, which by implication transforms 
colon epithelial cells and initiates polyp formation (31). 
Drosophila Groucho is the founding member of a conserved family of transcriptional co-
repressors. Other members of this family are found from C.elegans to vertebrates. The murine and 
human genome harbour four full-length homologs of Groucho as well as a gene that encodes a 
truncated Groucho protein. The human Groucho homologs are TLE-1, -2, -3, -4 (for Transducin- 
Like Enhancer of Split) and the truncated variant hAES (for Amino terminal Enhancer of Split). 
The mouse Groucho family consists of the Groucho-related genes, Grg-1, -2, -3, and -4 and the 
Grg-5 gene encoding a shorter variant (32). The Grg/TLE proteins are highly similar to 
Drosophila Groucho in their domain structure. They contain 5 protein domains: an amino terminal 
Q (Glutamine rich) domain, followed by a GP (glycin/proline rich) domain, a CcN domain 
(containing putative casein kinase II/cdc2 phosphorylation sites and nuclear localisation signal), a 
SP (serine/proline rich) domain and four WD40 repeats (protein interaction domain) (Figure 1B). 
Of these the Q and WD40 domain sequences are most highly conserved. Grg-5 and hAES encode 
only the two amino terminal domains of these proteins. Groucho related proteins have been 
described to tetramerize through a leucine zipper-like structure in the amino terminal Q domain 
(33). 
Groucho proteins function as co-repressors for specific subsets of DNA binding 
transcription factors, including the Hairy-related proteins, Runt domain proteins (34), Engrailed 
(35), Dorsal (36) Pax-5 (37), NK-3 (38), NK-4 (39), NF-κB (39) and HNF3β (40). For some of 
these transcription factors, the domain which interacts with Groucho is mapped to a short peptide 
motif. Hairy related bHLH transcription factors are involved in diverse developmental processes 
such as sex determination, segmentation, neurogenesis and myogenesis in the fly. The 
carboxyterminal WRPW motif of these bHLH transcription factors binds to the SP domain of 
Groucho, but also the WD40 domain may be involved (41, 35, 42). Runt domain proteins like 
Drosophila Runt and human AML associate with Groucho proteins through a related motif, 
VWPRY (34). Another conserved Groucho interaction motif is found in a number of transcription 
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factors such as Engrailed and Goosecoid that associate with Groucho through their eh1/GEH 
domain (35, 43). Engrailed has been shown to interact with the WD40 domain of Groucho (44). 
Dorsal, a Rel domain transcription factor involved in dorsal ventral patterning, has been described 
to associate with Groucho (36). Some of these transcription factors are genuine repressors, 
depending on Groucho for their activity, like Hairy (41), HES (45) and Blimp-1 (46). Others like 
Tcf (6), Runt (34) and Dorsal (36) are activators and convert to repressors upon association with 
Groucho-related proteins.  
Recently, the Drosophila histone deacetylase Rpd3 was shown to interact with Groucho 
(47). Recruitment of Rpd3 to the promotor of target genes will result in modulation of the local 
chromatin structure. Histone deacetylases remove acetyl groups from lysin residues in the amino-
terminal tails of core histones. By mechanisms which are not yet fully understood this appears to 
result in a more compact chromatin structure is being formed that is associated with a repressed 
transcriptional state (48). 
The current study characterises the Tcf/Groucho interaction in more detail. We describe 
the (co-) expression of individual Tcf and Grg/TLE family members in a panel of cell lines. In 
addition, we have mapped the Tcf interaction domain of Grg proteins and analysed whether there 
is specificity in the interaction between individual Tcf and TLE family members. Deletion 
analysis of XGrg-4 showed that only the first two domains, Q and GP, are sufficient to repress Tcf 
mediated transcriptional activation. However, Grg-5 which contains the same highly conserved 
domains, functions as a de-repressor. To determine the basis of the opposing functions of the 
truncated XGrg-4-QGP and XGrg-5 we examined their relative ability to interact with the human 
homolog of RPD3 (HDAC-1).  
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A B
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Figure 1. Domain structure of Tcf (A) and Grg (B) constructs.  
Tcf proteins contain a centrally located DNA-binding HMG box and the N-terminal β-catenin interaction domain. As 
previously reported (6) the Grg interaction domain is located between these domains. The Grg proteins contain five 
distinct domains: Q, GP, CCN, SP and WD40 regions (49), while Grg-5 consists only of the Q and GP domain. 
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Materials and Methods 
 
 
 
Transfections and Luciferase assays 
2.5 x 106 IIAI.6 B cells were transfected by electroporation with various combinations of a 
luciferase reporter plasmid containing three optimal Tcf sites upstream of the minimal HSV-TK 
promoter (1 µg of pTKTOP) or its negative control vector containing mutated Tcf sites (pTKFOP) 
in combination with the following plasmids: an internal transfection control (50 ng of pRNL-TK, 
Promega) and one ore more of the following expression constructs: Tcf expression vectors (2 µg); 
Grg expression plasmids (0.5 or 5.0 µg); β-catenin expression plasmid (5.0 µg). For repression and 
de-repression experiments (see Figure 5), 250 µg XTcf-3, 100, 50, and 25 ng Armadillo and 5 ng 
of Grg-5 or XGrg-4-QGP (1-197) expression plasmids were used. Additional pCDNA3 plasmid 
was included where necessary to make the total amount of DNA equivalent. cDNAs encoding 
hTCF-1, hLEF-1, XTcf-3, hTCF-4, and Myc-tagged versions of Grg-1, TLE-2, Grg-3 were 
expressed in pCDNA3. The expression construct for Grg-4 in pKW2T was kindly provided to us 
by Dr. M. Busslinger (Research Institute of Molecular Pathology, Vienna, Austria). Luciferase 
activities were determined 24 h after transfection using the DUAL luciferase system according to 
the manufacturer's protocol (Promega). Luciferase activity was normalised relative to RNL-
luciferase activity. For every experiment transfections were performed in duplicate and several 
independent experiments were performed. 
 
Yeast Two Hybrid Assay 
Two Hybrid experiments were carried out as described previously (2). Briefly, the Tcf (4-359) and 
Grg-5 (1-197) bait constructs were created by fusing the regions encoding the indicated amino 
acids to the GAL4 binding domain of pMD4. pVA3 encodes a murine P53-GAL4 binding domain 
hybrid in pGBT9 (Clontech). Multiple preys: mGrg-5 (1-197, 4-106, 82 –197, 4-62, 46-106, 82-
106) were inserted in frame with the GAL4 activation domain in pGADGH (Clontech) or 
pGADRX (Stratagene). pTD1 encodes SV40 large T antigen in pGAD3F (Clontech). Baits and 
preys were transformed into the Saccharomyces cerevisiae strain HF7C (Clontech) and true 
interactions were scored by growth on selective nutrient agar plates. Equivalent results were 
obtained monitoring β-galactosidase activity (data not shown). 
 
 
Cell lines 
For the transfection experiments the mouse B cell line IIAI.6 was used. For the reverse 
transcription coupled PCR experiments the following human cell lines were used as a source of 
RNA: Jurkat and CEM (T cell lines), Reh and Raji (B cell lines), 293T (embryonic kidney cell 
line), HT29, LS174, SW480, SW620, DLD-1, RKO (colon carcinoma cell lines) and SKBR3 and 
T47D (mammary carcinoma cell lines). Cells were cultured in RPMI-1640 supplemented with 
10% fetal calf serum and antibiotics. 
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Reverse transcriptase (RT)-PCR analysis 
Total RNA for detection of hTcf1, hLef-1, hTcf3, hTcf4, TLE-1, TLE-2, TLE-3 and TLE-4 was 
isolated from the different cell lines using RNAzolB solution (Tel Test inc.) according to the 
manufacturer's instructions. Random-primed cDNA from total RNA was prepared using standard 
techniques. The following primers were used for the different PCR reactions: for Tcf-1, Lef-1 and 
Tcf-4 PCRs specific primers were used to amplify part of the mRNA corresponding to the NH2-
terminus upstream of the HMG box. For hTcf-3 primers were developed to amplify the HMG box 
since this was the only sequence available at the time. Tcf1 primers: 5’-
ACCAGCGGCATGTACAAAGAG-3’ (sense), 5’-TTCAGGTTGCGGTCGAAGGGC-3’ 
(antisense). Lef-1 primers: 5’-TTCTCCACCCATCCCGAGAAC-3’ (sense), 5’-
CTGAGGCTTCACGTGCATTTAG-3’ (antisense). Tcf-4 primers: 5’-
CCATCACCGGCACACATTGTC-3’(sense), 5’-ACTATGGTGTGAGCCGACATC-3’. Tcf-3 
primers: 5’-GAAATCACCAGTCACCGTGAAA- 3’(sense), 5’-
ACCAGGTTGGGTAGAGCTGCG-3’ (antisense) 
For TLE-1, TLE-2, TLE-3 PCRs, specific primers were used to amplify a fragment of GP 
domain, CcN domain and part of the SP domain. For hTLE-4 a part of the WD domain was 
amplified since that was the only sequence available for this gene. hTLE-1 primers: 5’-
GGCAGTGCCGGCCTTCTTGCG-3’(sense), 5’-AGGCTTGCCGAGACCTGGACG-3’ 
(antisense). hTLE-2 primers: 5’-AGTGCTACGGGGCTGCTTGCT-3’(sense), 5’-
CGTTGAGAGTGCTGTGGGAGC-3’ (antisense). hTLE-3 primers: 5’-
AGCAGCTCCGGGCTGCTGGCA-3’(sense), 5’-AGCCGAGGCCATTATACCTAT-3’ 
(antisense). hTLE-4 primers: 5’-TACACGGGTGGGAAGGGCGCG-3’(sense), 5’-
GGCTTGGTGACATGCAAAACT-3’ (antisense) 
The primers for the GAPDH control PCR: 5’-AAGGTGAAGGTCGGAGTCAAC-3’(sense) 5’-
TTACTCCTTGGAGGCCATGTG-3’(antisense) 
 
Immunopreciptations 
293T cells were co-transfected with pCDNA3-Flag-HDAC-1 (kindly provided to us by T. 
Kouzarides, Wellcome/CRC Institute Cambridge, UK) and pCDNA3-MYC-QGP-XGrg4 (amino 
acid 1-197) or pCDNA3-MYC-Grg5. Cells were harvested and whole cell lysate was prepared in 
Triton X-100 lysisbuffer (20 mM Tris ph 8.0, 140mM NaCl, 1% triton X-100 and 10% Glycerol) 
containing protease inhibitors (Protease inhibitor cocktail tablets; Roche Diagnostics) The extract 
was incubated with 1 µg anti-Myc monoclonal antibody and 5 µl protein A/G beads (Santa Cruz) 
or with 5 µl FLAG coupled beads (Sigma) over night at 4oC in Triton X-100 lysis buffer. The 
beads were washed twice in Triton X-100 buffer and twice in Wash buffer (20 mM Tris pH 8.0, 
150 mM NaCl and 0.5% NP-40) Supernatants were resolved by SDS-PAGE and transferred on 
nitrocellulose membrane (Immobilon-P, Millipore) The membrane was incubated with anti-FLAG 
(Sigma) or anti-Myc antibodies and immune reactive proteins were visualised by enhanced 
chemiluminescence. (Amersham Pharmacia Biotech) 
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Results and discussion 
 
 
 
A 100 amino acid region in Grg-5 is essential for interaction with Tcf  
 
 The interaction between Tcf and Grg was previously mapped to the QGP domains of 
Groucho since Tcf interacts with Grg-5, consisting only of these two domains (50). Grg proteins 
can also tetramerize through their Q domain (33). We used the yeast two-hybrid assay to more 
precisely map the domain of Grg that interacts with Tcf versus the domain that is responsible for 
multimerization with other Grg molecules (Figure 2). Constructs expressing different parts of Grg-
5 were fused to the Gal-4 activation domain and their interaction with Tcf-1 (4-359) and Grg-5 (1-
197) fused to the gal-4 DNA binding domain was determined. The results shown in figure 2 imply 
that the Tcf interaction domain resides in the first 106 amino acids of Grg-5. All other deletion 
constructs of Grg-5 failed to interact with Tcf. Our data indicate that this N terminal region also 
contains the Grg interaction domain, in accordance with the domain previously described to 
mediate tetramerization (33). Further truncation of this region probably prevents proper folding of 
the tetramerization domain and thereby results in loss of the interaction with both Grg and Tcf.  
 
 
 
 
Figure 2. Mapping of the Grg-Tcf interaction domain and Grg multimerization domain. 
The different bait Grg-5 constructs used in the yeast two hybrid assay are shown on the left. The ability of these 
constructs to interact with prey molecules Tcf-1 (4-359) or Grg-5 (1-197) and allow growth of yeast on selective 
plates is indicated. The minimal interaction domain of Grg-5 required for interaction with Tcf resides in the first 106 
amino acids. Further truncation of this domain results in loss of interaction. 
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Repression of TCF mediated transcription by Groucho related genes 
 
To further investigate the issue of specificity in the interaction between different Tcf family 
members and Grg proteins, we used the previously established β-catenin-Tcf reporter gene assay 
(3). In this assay co-transfection of Tcf and β-catenin results in transactivation of a luciferase 
reporter gene, which we previously demonstrated could be repressed by introduction of Groucho 
(6). Here the four different Tcf family members were co-transfected with β-catenin and increasing 
amounts of either Grg-1, TLE-2, Grg3 or Grg-4. An expression construct of human TLE-2 was 
included in stead of mGrg-2 for the latter had not been described at the time. Three human Tcf 
family members were used hTcf-1, hLef-1, hTcf-4 (Figure 3A, B, and D respectively). For Tcf-3 
we used the Xenopus ortholog (Figure 3C) because human Tcf-3 proved difficult to express (data 
not shown). Identical transfections were carried out using the reporter with mutated Tcf sites. A 
Renilla luciferase vector was also transfected to correct for transfection efficiency. [Note that the 
B cell line used for these assays expresses moderate levels of both Grg-1 and Grg-4. (6)] These 
experiments show that all different Grg proteins can repress transcriptional activation mediated by 
all Tcf family members. Grg-1 and Grg-4 seem to be more potent repressors than Grg3 and TLE-
2. In this assay the Tcf proteins show differences in transactivation capacity: hTcf-1 and Lef-1 
transactivate stronger than XTcf-3 and hTcf-4, but for all Tcf family members repression is 
observed upon co-transfection with the different Groucho homologues.  
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Figure 3. All 'long' Grg proteins can repress transactivation mediated by all Tcf family members. 
Mouse B cell line IIAI.6 was co-transfected with the Tcf reporter construct (containing either wild-type Tcf binding 
sites, TOP-TK, or mutated Tcf binding sites, FOP-TK as a negative control) and a specific Tcf family member and β-
catenin. This results in the transactivation and increase of luciferase activity. Upon addition of increasing amounts of 
any of the Grg family members, the luciferase activity decreases proportionally. Transfections were performed in 
duplicate, and results from one representative independent experiment are depicted in each case. luciferase values 
were corrected for the efficiency of transfection using the internal Renilla transfection control by determining the 
luciferase/Renilla ratio. This ratio is given on the Y-axis, and was arbitrarily set at 1 for the sample in which the TOP-
TK reporter construct alone was transfected. 
 
A. Repression of Tcf-1 mediated transcriptional activation by Grg-1, TLE-2, Grg-3 and Grg-4 
B. Repression of Lef-1 mediated transcriptional activation by Grg-1, TLE-2, Grg-3 and Grg-4 
C. Repression of Tcf-3 mediated transcriptional activation by Grg-1, TLE-2, Grg-3 and Grg-4 
D. Repression of Tcf-4 mediated transcriptional activation by Grg-1, TLE-2, Grg-3 and Grg-4 
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Expression of the different Tcf and TLE family members in a panel of cell lines 
 
We examined whether there was any specificity in the interaction between Tcf and TLE 
proteins based on their expression pattern in a panel of cell lines. Two B cell lines, Reh and Raji 
and two T cell lines, Cem and Jurkat were tested, as well as a number of colon carcinoma cell 
lines (HCT116, LS174, HT29, DLD-1, SW480, SW620 and RKO) and two mammary carcinoma 
cell lines (T47D and SKBR3). In colon carcinoma cell lines the Wnt signaling cascade is 
constitutively activated. In all but one (RKO) of these colon carcinoma cell lines, mutations in 
either APC or β-catenin have been identified. Absence of TLE expression in the RKO cell line 
could potentially account for activation of the pathway in this cell line. 
 RNA was isolated from the above cell lines and first strand cDNA was prepared by reverse 
transcription (RT). This cDNA was used as a template in PCR to assay for the expression of the 
different Tcf and TLE family members (Figure 4). As a negative control, reverse transcriptase was 
omitted from the RT reaction. PCR for the different Tcf and TLE family members was carried out. 
A GAPDH PCR served as a internal control for the quality of the prepared cDNA. The PCR 
products were designed to be of different sizes to distinguish between the different family 
members. A product of each PCR was sequenced to confirm the identity of the amplified product 
and to exclude any cross reactivity between family members (data not shown).  
Expression of hTCF-1 was detected in all cell lines tested except in the B cell lines. In the 
cell lines where hTCF-1 is expressed a very faint band was also observed running more slowly in 
the gel. This corresponds to a splice variant of Tcf-1 containing an extra exon as described earlier 
(51). hLEF-1 expression was found in Reh, CEM, Jurkat, 293T, LS174T, DLD-1, SW480, 
SW620, RKO and T47D. It was known previously to be expressed in pre-B and T cells and 
several other cell types (25), but apparently it is not expressed in all colon- or mammary 
carcinoma cell lines. The two different products present in most hLEF-1 expressing cell lines 
correspond to the presence of two different splice variants (52) as was confirmed by sequencing 
(data not shown). hTCF-3 expression was restricted to Jurkat, 293T, some colon carcinoma cell 
lines (HCT116, DLD-1, SW480 and SW620) and both mammary carcinoma cell lines T47D and 
SKBR3. For this family member a more restricted expression pattern was expected since hTCF-3 
is mainly expressed during early embryogenesis (27). hTCF-4 is expressed ubiquitously in all cell 
lines tested.  
 The expression of the Groucho family members also showed a relatively broad pattern. 
Within this panel of cell lines, only the expression pattern of hTLE-2 was restricted, being 
expressed in Reh, Jurkat, HCT-116, RKO, T47D and SKBR-3. For hAES, hTLE-1, hTLE-3and 
hTLE-4 a broad expression pattern was observed. hAES is expressed in all cell lines tested but at a 
low level in Raji, 293T and T47D. hTLE-1 is only absent in Raji and SW620 cell lines. hTLE-4 is 
present in all cell lines of this panel with the exception of HCT116 and LS174T. hTLE-3 is present 
in all cell lines in this panel. Corresponding with this broad expression of TLEs in cell lines, it has 
been shown that the TLE proteins are also broadly expressed in adult tissues (49). 
These data show that a number of diverse cell lines all express multiple TCF and TLE 
family members. This indicates that the pattern of expression does not contribute to a possible 
specificity of interaction between Tcf and TLE molecules. It does imply, however, that two or 
more Groucho repressor proteins are normally available for a tight control over the TCF 
transcriptional activation pathway, since deregulation of this pathway can result in tumorigenesis, 
as has been shown for colon carcinoma (31) and melanoma (53).  
Chapter 2 
 44 
 
 
 
Figure 4. Expression of hTCF-1, hLEF-1, hTCF-3, hTCF-4 (A), TLE-1, TLE-2, TLE-3, TLE-4 and hAES (B)  
Expression was determined by RT PCR using cDNA generated from a panel of cell lines. Reh (lane 1), Raji (lane 2), 
CEM (lane 3), Jurkat (lane 4), 293T (lane 5), HCT116 (lane 6), LS174T (lane 7), HT29 (lane 8), DLD-1 (lane 9), 
SW480 (lane 10), SW620 (lane 11), RKO (lane 12), T47D (lane 13), SKBR3 (lane 14) and H2O control for the PCR 
(lane 15). The lane marked with λ depicts the DNA marker (bacteriophage DNA digested with EcoRI and HindIII) 
Expression is tabulated for Tcfs and TLEs for the given cell lines. + visible RT-PCR product; -, no visible RT-PCR 
product 
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Domains of Grg required for repression of Tcf mediated transactivation and dependency on 
HDAC interaction 
 
Deletion constructs of Xenopus Grg-4 (XGrg-4) were tested for their ability to repress Tcf 
mediated transcriptional activation (data not shown). The minimal construct of XGrg-4 required 
for repression consists of only the first two N-terminal domains. This truncation of XGrg-4, 
consisting of amino acids 1-197, encodes the Q domain, involved in tetramerization and 
interaction with Tcf, and the GP domain, essential for interaction with the histone deacetylase-1, 
HDAC (47). This construct is highly homologous to Grg-5, which is comprised of only the Q and 
GP domains, but functions as a de-repressor (6) (Figure 5A). In figure 5B, an alignment of the GP 
domains of mGrg-1, mGrg-3, XGrg-4 and mGrg-5 is depicted, showing the high homology 
between these proteins. The amino acids unique for Grg-5 are indicated in bold.  
Cells were transfected with the Tcf reporter construct (TK-TOP), XTcf-3 and different amounts of 
Armadillo (the Drosophila homologue of β-catenin). XGrg-4-QGP consistently repressed 
transcription while Grg-5 enhanced the Armadillo mediated transactivation (Figure 5C.) 
 
 
 
Figure 5. Comparison of Grg-5 with XGrg-4-QGP 
A. The structure of the truncated XGrg-4 QGP molecule compared to that of Grg-5.  
B. Alignment of the GP domains of long Grg-homologues with mGrg-5. The amino acid residues that are unique for 
mGrg-5 when compared to mGrg-1, mGrg-3 and XGrg-4 are depicted in bold.  
C. XGrg-4-QGP functions as a repressor, but mGrg-5 functions as a de-repressor for Tcf mediated transcriptional 
activation. Mouse B cell line IIAI.6 was co-transfected with the Tcf reporter construct (TOP-TK), XTcf-3 and 
Armadillo (the Drosophila β-catenin homologue). This results in transactivation and increase in luciferase activity. 
This transactivation is de-repressed when Grg-5 is co-transfected, whereas the transactivation is repressed upon co-
transfection with a truncated version of XGrg-4 that only contains the Q and GP domains. transfections were 
performed in duplicate and luciferase values were corrected for the efficiency of transfection using the internal Renilla 
transfection control pRNL-TK by determining the luciferase/Renilla ratio. This ratio is given on the y-axis 
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             The GP domains of proteins of the Groucho family are highly conserved, and this domain is 
involved in interaction with HDAC (47). The subtle differences between the GP domain of the 
long Groucho homologs and the GP domain of the shorter variants like Grg-5 are possibly 
responsible for these antagonistic functions (Figure 5B). To address this, the interaction of HDAC 
with XGrg-4-QGP and mGrg-5 was studied in immunoprecipitation experiments (Figure 6). A 
Flag-HDAC-1 construct was co-transfected with the Myc-tagged Grg constructs of mGrg-5 and 
the truncated XGrg-4-QGP. Cell lysates were immunoprecipitated with anti-Myc antibody and 
protein A/G beads. The presence of HDAC was assayed on an immunoblot using the Flag 
antibody. Figure 6A shows that precipitation of Myc tagged Grg-5 and XGrg-4-QGP results in co-
precipitation of HDAC with XGrg-4-QGP (lane 3) but not with Grg-5 (lane 4), although HDAC 
expression in the lysate of the cells co-transfected with Grg-5 and HDAC-1 is apparent (lane 5). 
Lanes 6 and 7 show that the two Myc tagged Grg constructs were immunoprecipitated with 
similar affinity. Similar results are obtained when Flag tagged HDAC is immunoprecipitated and 
the presence of mGrg-5 and XGrg-4-QGP is assayed (Figure 6B). Precipitation of Flag tagged 
HDAC co-precipitates XGrg-4-QGP but not Grg-5 (Figure 6B, lanes 3 and 4, respectively). 
Association of HDAC with full length Grg-3 was also observed (data not shown). 
 
 
 
 
Figure 6. HDAC-1 associates with XGrg-4-Q-GP, but not with mGrg-5. 
293T cells were transfected with either Myc-tagged XGrg-4-QGP or Myc-tagged mGrg-5 alone (lanes 1 and 2), or 
with a Flag-tagged HDAC-1 (lanes 3 and 4). Cell lysates were prepared 24 hours after transfection.  
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A. Extracts from transfected cells were immunoprecipitated (IP) with an anti-Myc antibody against Myc-tagged 
XGrg-4-QGP and Myc-tagged mGrg-5, and the presence of Flag-HDAC-1 in the immunoprecipitate was assayed on 
immunoblot (IB) with ant-Flag antibody. In lanes 1 and 2 only Myc-tagged XGrg-4-QGP or Myc-tagged mGrg-5 
were transfected. In lanes 3 and 4 Myc-XGrg-4-QGP or Myc-Grg-5 were co-transfected with Flag-tagged HDAC-1. 
Lane 5 shows the presence of HDAC-1 in the co-transfection of Myc-Grg-5 and Flag-HDAC. 
B. Extracts from transfected cells were immunoprecipitated (IP) with an anti-Flag antibody against Flag-HDAC-1. 
The presence of Myc-XGrg-4-QGP and Myc-Grg-5 was assayed ion immunoblot (IB) with anti-Myc antibody. In 
lanes 1 and 2 only Myc-XGrg-4-QGP or Myc-Grg-5 were transfected. In lanes 3 and 4, Myc-XGrg-4-QGP or Myc-
Grg-5 were co-transfected with Flag-HDAC-1. Lanes 5 and 6 show an immunoblot with anti-Myc antibody, 
indicating the expression of Myc-XGrg-4-QGP or Myc-Grg-5 when co-transfected with Flag-HDAC-1.  
Bands corresponding to HDAC, Grg-5, XGrg-4-QGP are indicated with arrows. Bands labelled "Ig" indicate the 
heavy and light chains of the antibodies used for the immune precipitation. 
 
 
 
These data show that the long, repressive vertebrate Groucho homologs readily associate 
with the histone deacetylase HDAC-1 as was described previously in the fly (47). The de-
repressor Grg-5, however, does not bind HDAC, explaining why Grg-5 does not function as a 
repressor.  
Grg-5 may function to fine-tune the repression mediated by Groucho family members. In 
one possible model, Grg-5 would associate with long repressive Grg proteins and thereby 
decreases the amount of HDAC that is tethered to the template, reducing the level of repression. 
Alternatively, Grg-5 could bind directly to a subclass of transcription factors interacting with the 
first two domains of Groucho and prevent long Grg family members associating with such factors, 
abrogating repression entirely (Figure 7). In vivo, the precise activation status of a given 
transcription factor interacting with Groucho proteins would be partially determined by the mutual 
antagonism between long and short forms, the balance of which could be influenced by protein 
expression levels, sub cellular distribution or post-translational modifications of Groucho proteins. 
 We find no specificity in the interactions between the different members of the Tcf and 
Groucho families. Every cell line tested expresses several TLE and TCF family members. Further 
more, reporter assays reveal that any long Grg can repress any given Tcf, suggesting that all 
partners are capable of interacting in vivo. The abundance of Groucho molecules and the 
redundancy with which they interact with TCF proteins probably highlights the requirement to 
silence target gene expression adequately, in order to prevent unrestrained cell growth and/or 
aberrant differentiation, hall marks of cancer cells. It still remains a possibility that some 
specificity is achieved by other means not identified in this study. For example, TLE 
phosphorylation may influence their repressive activity, since CDC2 and Casein Kinase II 
consensus sites are found in the Grg/TLE sequences and it has previously been shown that the 
TLE phosphorylation pattern changes during differentiation (54). 
 The mechanism of Groucho mediated repression remained unclear until recently, when it 
was shown that Groucho functionally interacts with the histone de-acetylase Rpd3 (47). 
Recruitment of Rpd3 to a target promotor would result in modification of the local chromatin 
structure and, consequently, the formation of a more compact chromatin structure, associated with 
a repressed transcriptional state. This is likely the main mechanism through which Groucho 
related proteins exert their function, although other data indicate an additional mechanism of 
repression may exist. When different Grg constructs are tethered to a Gal4 DNA binding domain, 
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domains capable of mediating repression are also found outside the GP domain (41). Moreover, 
when Groucho mediated repression is assayed in the presence of the HDAC inhibitor Trichostatin 
A, some residual repression activity remains (47). When the histone deacetylase Rpd3 in 
Drosophila is mutated, only mild defects are observed (55). All these studies suggest that HDAC 
is an important, but not the sole, mediator of transcriptional repression. Further study of the 
mechanism of Groucho mediated repression will address these subjects in the future. 
 
 
 
 
Figure 7. Model for Tcf , "long" Grg and Grg-5 functions. 
Expression of Tcf target genes is activated when Tcf is associated with β-catenin and repressed when Tcf binds 
Groucho. Here we show that the function of Grg-5 provides another level of regulation. When in a complex, both the 
long repressor Grg and Grg-5 are bound to Tcf, a less competent repressor is formed, since less HDAC activity is 
tethered to the promotor. When Grg-5 replaces the longer repressor proteins entirely from the complex with Tcf, 
repression is absent because HDAC activity is lacking. 
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Abstract 
 
 
 
 Groucho proteins comprise a family of very conserved transcriptional co-repressors, which 
are found in a broad range of species, ranging from mammals to Xenopus and Drosophila. In 
mouse there are five family members denoted Groucho-related genes: Grg-1, Grg-2, Grg-3, Grg-4 
and Grg-5. Groucho repressors do not bind DNA directly, but affect transcription by binding 
transcription factors. A large variety of transcription factors including Hairy related genes (1), 
Runt domain proteins (2) and TCF/LEF factors (3;4) are known to use Groucho proteins to 
mediate repression. Recently we demonstrated that the five Grg family members can all 
functionally interact with each of the four different TCF proteins (5). In an attempt to determine if 
there is any specificity in the interaction between TCF and Grg proteins on the basis of their 
expression patterns in embryonic mouse tissues, we raised monoclonal antibodies specific to Grg-
1, Grg-2, Grg-3, Grg-4 and Grg-5. 
 
 
 
 
 
Introduction 
 
 
 
 The family of Groucho proteins is a conserved family of transcriptional co-repressors. 
Members of this protein family are present in many species, including human, mouse, frog, zebra 
fish, chicken and worm. Drosophila Groucho, the founding member of these proteins, comprises 
five different domains (Figure 1): an amino terminal Q (Glutamine rich) domain, followed by a 
GP (glycin/proline rich) domain, a CCN domain (containing putative casein kinase II/cdc2 
phosphorylation sites and nuclear localisation signal), a SP (serine/proline rich) domain and four 
WD40 repeats (protein interaction domain) (6). In Drosophila, Groucho is the single family 
member present, whereas four different five-domain-containing Groucho homologs are present in 
both human (TLE-1, -2, -3, -4, for transducin-like enhancer of split) (7) and mouse (Grg-1, -2, -3, 
-4, for Groucho related genes). In addition, a family member has been identified in humans, AES1 
(amino terminal enhancer of split) and in mice, Grg-5 (8), that resembles a truncated variant 
consisting of only the first two N-terminal domains. 
 As co-repressors, Groucho proteins do not bind DNA directly, but are recruited to the 
promotors by interacting with a variety of DNA binding transcription factors to modulate their 
transcriptional activity. One class of Groucho interacting proteins are DNA binding factors that 
function solely transcriptional repressors where Groucho provides the repressive activity, e.g. 
Hairy related proteins (1;9), Engrailed (10;11), Brinker (12) and NK-3 and -4 (13;14) 
Alternatively, transcriptional activators, such as Dorsal (15), TCF/LEF factors (3;4) and PAX-5 
(16) can be modified to become transcriptional repressors upon association with Groucho proteins. 
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Groucho proteins function as transcriptional co-repressors by binding to histone deacetylases 
(HDACs) (17,18). HDACs de-acetylate the N-terminal lysine tails of histones, restoring a positive 
charge which facilitates DNA wrapping around histone structures, thus condensing the chromatin 
structure of the DNA and making it less accessible for transcription factors. In general, decreased 
acetylation levels of chromatin are associated with repression of gene expression (19). 
 Previously, we described that all five mouse Groucho proteins can interact with each of the 
four different Tcf family members (5). Transcriptional activation by the individual TCF/LEF 
proteins can be repressed by each Grg protein. We raised monoclonal antibodies against the 
different mouse Grg proteins to determine if there is any specificity between the Tcf-Grg 
interactions based on expression patterns in the mouse embryo. In this report we describe the 
generation of mouse monoclonal antibodies specific for Grg-1, Grg-2, Grg-3, Grg-4 and Grg-5 
and their functionality in several assays. 
 
 
 
 
 
Materials and Methods 
 
 
 
Cell lines and reagents 
COS and 293T cell lines were routinely cultured in RPMI (Life Technologies), supplemented with 
10% fetal calf serum, and antibiotics. 
 
Production and purification of the His-tagged fusion proteins. 
His-tagged proteins were constructed by cloning different PCR fragments into a pET 21 plasmid: 
mGrg-1 a PCR fragment corresponding to 765-1061 bp (tcttctcca…gcagcagct), mGrg-2 822-1123 
bp (cctgtgacc…agcagctct), mGrg-3 601-993 bp (atgacggag…aagagtgac), mGrg-4 351-742 bp 
(atggcagaa…agagtgat) and mGrg-5 431-684 bp (acggctcct…aagtcggat). The bacterial strain BL21 
was transformed with these recombinant plasmids and cultured in LB ampicillin medium (100 
µg/ml) at 37oC till an OD of 0.6. Isopropyl-1-thio-β-D-galactopyranoside was added to a final 
concentration of 1 mM to induce production of the different histidine fusion proteins, the bacteria 
were cultured for an additional 3 hours. Bacteria were harvested by centrifugation for 15 minutes 
at 4000X g at 4oC and the pellet was resuspended in 8 ml ice cold binding buffer (5 mM 
imidazole, 500 mM NaCl, 160 mM Tris HCl, pH 7.9). The suspension was sonicated for 10 
minutes and subsequently centrifuged at 10.000 rpm for 45 minutes at 4 oC. The supernatant was 
passed over a Ni2+ column and the bound Grg-His fusion proteins were eluted in fractions of 1 ml 
of elution buffer (20 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH7.9) 
 
Generation of mouse monoclonal antibodies 
Six week old BALB/c mice were immunized by intraperitoneal injection of 100 µg of fusion 
protein in Freund’s complete adjuvant (Difco) with a second injection in Freund’s incomplete 
adjuvant (Difco) 14 days later. Three to five additional injections were performed with 100 µg 
fusion protein in PBS at weekly intervals. A mouse with titer 1/1000 was sacrificed, the spleen 
isolated and 1x 108 splenocytes were fused with a ratio of 2:1 with SP2/0 mouse myeloma cells 
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using polyethylene glycol. The fused cell population was resuspended in hypoxanthine 
aminotropterin thymidine selection medium (Life) and plated into twenty 96-well flat bottom 
culture plates. Supernatants were screened 10-14 days after the hybridoma fusion. Positive 
hybridomas were repeatedly sub cloned to generate clonal hybridomas secreting monoclonal Grg-
1, mGrg-2, mGrg-3, mGrg-4 and mGrg-5 antibodies. 
 
Hybridoma screening assay 
To screen the hybridoma supernatants, approximately 10x106 COS cells were transiently 
transfected with 10 µg pCDNA3 vector containing Myc-mGrg-1, Myc-mGrg-2, Myc-mGrg-3, 
Flag-mGrg-4 or Myc-mGrg-5 constructs using DEAE Dextran, according to standard procedures. 
Cells were subsequently plated into 96-well flat bottom culture plates at a concentration of 104 per 
well. Cells were cultured for 48 hours, washed once with PBS, fixed with methanol and stored at -
20oC. For screening the plates were washed with PBS and incubated with the hybridoma 
supernatants for 60 minutes. As a positive control staining with anti-Myc or anti-Flag antibody 
was used. Detection was carried out with peroxidase labelled rabbit-α-mouse horseradish 
peroxidase 1:100 (DAKO) and 0.02% aminoethylcarbonate / 0.1% hydrogen peroxide in 0.1 M 
sodium acetate, pH 4.8 as a colour substrate. Individual wells were examined for staining using an 
inverted microscope. 
 
Western blotting 
For detection of transfected Grg protein, approximately 0.3 x 106 293T cells were transfected with 
an expression vector (pCDNA3) for a full length Grg protein using fugene (Roche) according to 
manufacturer's instructions. 24 hours after transfection the cells were lysed in 200 µl of 2X SDS-
PAGE sample buffer (15 mM 1 M Tris pH6.8, 5% SDS, 40% Glycerol, 0.005% BPB, 8% β-
mercapto-ethanol), vortexed vigorously, denatured by heating at 98oC for 5 min and sonicated. 10 
µl of protein extract was resolved on a 10% (w/v) denaturing polyacrylamide gel, and transferred 
to PVDF membrane (Immobilon-P, Millipore). The protein was detected by probing the blot for 
one hour in the hybridoma supernatant (cleared by centrifugation 15 minutes at 4000 g) followed 
by a horse-radish-peroxidase-conjugated rabbit anti-mouse IgG polyclonal antibody (Pierce), and 
finally visualized by enhanced chemiluminescence (Amersham). 
 
Immunohistochemistry 
Mouse embryos were harvested between time points E10.5 and E16.5 days, and fixed in NOTOX 
(Yvsolab) at 4°C. They were subsequently embedded in paraffin and sectioned at 5µm thickness. 
After de-paraffination, endogenous peroxidase activity was blocked by incubating the sections in 
1.5% peroxide in methanol for 20 minutes. The sections were then boiled in 0.01 M citrate, pH 6.0 
or in Tris/EDTA (40 mM/1mM, pH 8.0) buffer pH 8, for 20 minutes and cooled slowly. Before 
staining, the sections were blocked with 1% BSA in phosphate buffered saline (PBS) for 15 
minutes. The sections were washed in PBS and incubated with hybridoma culture supernatant for 
60 minutes. The sections were washed in PBS and the primary antibody was detected with Poly-
HRP-goat-α-mouse IgG (Immunovision) and DAB solution. 
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Results and discussion 
 
 
 
 Mice were immunized with recombinant Grg proteins to generate monoclonal antibodies 
against the different Grg family members. The proteins fragments used for immunizations were 
carefully designed from unique regions to prevent cross reactivity between the antibodies against 
these highly related proteins (Figure 1). The chosen fragment of each cDNA was cloned into the 
pET21 vector and large amounts of protein were produced and purified using the HIS tag of the 
constructs. The Grg-2, -3, 4-, and -5 constructs readily produced several mg of protein, whereas 
several different constructs had to be tested before sufficient Grg-1 recombinant protein was 
obtained. 
 
 
 
 
 
Figure 1. Protein alignment of the mouse Grg protein family members Grg-1, Grg-2, Grg-3, Grg-4 and Grg-5. 
In mouse there are five Groucho family members. The "long" variants Grg-1, -2, -3, and -4 contain of five distinct 
domains: Q, GP, CCN, SP and WD40 regions, whereas the short variant Grg-5 only consists of the two N-terminal 
domains, the Q and GP domains. The regions of the individual Grg proteins used to generate antibodies are indicated 
in the grey box. 
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 The first fusion experiment of myeloma cell line SP2/0 with splenocytes from a mouse 
immunized with Grg-1 protein resulted in one clonal hybridoma cell line producing antibodies 
reactive with both Grg-1 and Grg-4 (data not shown). Another construct was designed, this time 
resulting in excess of 1700 hybridomas. Five of these were positive on COS cells transfected with 
mGrg-1. These were sub cloned and only two (42.2 and 44.1) were still positive for Grg-1 and did 
not cross react with Grg-4. 
 Fusion of the splenocytes of the Grg-2 immunized mice with the SP2/0 cell line yielded in 
excess of 1500 hybridomas. Fifteen of these supernatants reacted positively on mGrg-2 transfected 
COS cells. After sub cloning, two hybridomas (9E4 and 3D4) continued to specifically recognize 
Grg-2 in transfected COS cells. 
 The fusion experiment yielding monoclonal lines producing Grg-3 antibody, resulted in 
excess of 1500 hybridomas. Twenty-nine of these were positive in the first screen on mGrg-3 
transfected COS cells. These were sub cloned, resulting in the generation of three monoclonal 
hybridoma lines, BG11, AA8 and CC3. 
 The fusion experiment for Grg-4 antibody producing lines resulted in excess of 1500 
hybridomas. Eight were positive on mGrg4 transfected COS cells and after sub cloning 6 lines 
remained which produced anti-Grg-4 antibodies (GE11B4, NB886, F11B4, GR11C7F6, 
FB8C11D9, DD9CF05). 
The fusion between the SP2/0 cell line and splenocytes from mice immunized with mGrg-5 
protein yielded 1800 hybridomas, of which 2 were positive. These were sub cloned, resulting in 
two monoclonal lines (MG3 and KF12). 
 
 
 
 
Characterization of the specificity of the monoclonal antibodies directed against the Grg 
proteins 
 
 The supernatants were tested on COS cells transfected with Myc-Grg-1, Myc-Grg-2, Myc-
Grg-2, Myc-Grg-3, Flag-Grg-4 and Myc-Grg-5 to determine the specificity of the monoclonal 
antibodies produced by these hybridomas. The antibodies were shown to be specific for the Grg 
family member they were raised against. (Figure 2.) 
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Figure 2. Characterization of the monoclonal antibodies specificity on transfected COS cells. 
COS cells were transfected with Flag or Myc- tagged expression vectors of the different Grg family members, Myc-
Grg-1 (row 1), Myc-Grg-2 (row 2), Myc-Grg-3 (row 3), Flag-Grg-4 (row 4) and Myg-Grg-5 (row 5). Supernatant 
with the monoclonal antibodies raised against the different Grg proteins were used to stain these COS cells, anti-Grg-
1 in column 1, anti-Grg-2 in column 2, anti-Grg-3 in column 3, anti-Grg-4 in column 4 and anti-Grg-5 in column 5. 
The transfected COS cells were stained with the Myc or Flag antibody to control for expression of the Grg proteins 
(column 6). 
 
 
 
 The hybridomas were subsequently tested for reactivity and specificity by Western blot. 
293T cells were transfected with tagged versions of the cDNAs for the different Grg proteins. A 
blot with lysates of Grg-1, Grg-2, Grg-3 and Grg-4 was incubated with the selected supernatants. 
Cross reactivity with the much smaller Grg-5 protein was determined on a separate blot. All 
supernatants for the Grg proteins were found to be reactive in Western blot and exhibited no cross 
reactivity (Figure 3.) The antibodies were also tested for detection of endogenous protein in mouse 
tissue extracts, but without success. Possibly the expression levels of endogenous proteins were 
too low to be detected in this way. 
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Figure 3. The antibodies against the mouse Grg proteins are specific for the different family members on 
Western blot. 
Cell extracts from 293T cells transfected with Myc-Grg-1 (lane 1), Grg-2 (lane 2), Myc-Grg-3 (lane 3), Flag Grg-4 
(lane 4) and Myc Grg-5 (lane 5) were analyzed by Western Blot with the supernatants containing the Grg monoclonal 
antibodies α-Grg1 (A), α-Grg-2 (B), α-Grg3 (C), α-Grg-4 (D), α-Grg-5 (E) 
 
 
Immunohistochemistry with the monoclonal antibodies directed against the Grg family 
members 
 
The monoclonal antibodies were initially designed to determine the expression pattern of 
the different Grg proteins in mouse tissues. The supernatants, and later the purified versions, were 
therefore tested on immunohistochemistry. Only the antibody against Grg-3 worked in this assay 
(Figure 4). This protein demonstrated ubiquitous nuclear expression. Several variations of the 
procedure were tested for the other antibodies, including the use of different fixatives (formalin or 
NOTOX or frozen sections) different antigen retrieval methods, different secondary antibodies. 
However, none of the other antibodies showed any specific staining using these methods. 
 
 
 
Figure 4. Grg-3 expression in the mouse embryo 
Day 16 mouse embryo tissue sections were stained with the Grg-3 antibody, showing an ubiquitous expression of 
mGrg-3 in the different tissues, brain (A), notochord and cartilage (B), whiskers (C), heart (D), lung (E), liver (F), 
kidney (G) and colon (H). 
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The expression of the different Grg family members was determined by Northern Blot on 
mouse tissues, to get additional information on their expression pattern. RNA was isolated from 
several mouse organs: brain, thyroid gland, thymus, heart, lung, spleen, liver, kidney, stomach, 
small intestine, colon and testis. Northern blot experiments were carried out using probes for the 
different mGrg RNA's (Fig. 5). Grg proteins, like their human TLE counterparts (20), were quite 
ubiquitously expressed. However the expression pattern of Grg-2, was much more restricted, 
being found only in heart tissue. 
 
 
Figure 5. Expression of the different Grg family members in mouse tissues by Northern blot. 
RNA was isolated from a selection of adult mouse tissues: testis (lane 1), colon (lane 2), small intestine (lane 3), 
stomach (lane 4), kidney (lane 5), liver (lane 6), spleen (lane 7), lung (lane 8), heart (lane 9), thymus (lane 10), thyroid 
gland (lane 11) and brain (lane 12). Probes specific for the different Groucho family members were used: Grg-1 (A), 
Grg-2 (B), Grg-3 (C), Grg-4 (D) and Grg-5 (E). 
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 Here we present the generation of specific monoclonal antibodies against the five different 
members of the Grg protein family. These proteins are fully active when used to stain methanol 
fixed transfected cells and in western blot procedures on transfected proteins. Only the mGrg-3 
showed activity in immunohistochemistry, showing that the protein is ubiquitously expressed at a 
high level. Regrettably, the other Grg antibodies are not appropriate for immunohistochemistry, so 
the expression patterns of the different Grg proteins in mouse tissues could not be revealed. To 
address this issue alternative techniques can be applied such as in situ hybridization. The specific 
expression of Grg-2 as revealed by Northern blotting might indicate a unique role for Grg-2 in 
heart tissue and could be interesting to be studied in more detail. 
 However, the antibodies described here will be useful in biochemical experiments. They 
could be used to confirm the interaction between Groucho and novel binding partners or they 
could be instrumental to study the mechanism whereby Grg proteins function. Grg proteins occur 
in large protein complexes with transcription factors, HDACs, possibly containing proteins of the 
Sir-3 repressor complex (21). The exact composition of this complex could be determined into 
more detail using the Grg antibodies in large scale protein purification experiments. Moreover, it 
has been described that not all repression conferred by Groucho can be explained by HDAC 
activity, since the HDAC inhibitor TSA can only partially block Groucho mediated repression 
(17) and there are also domains outside the HDAC interaction domain that contain repression 
activity (9). By purifying this so called repressosome, additional novel components involved in 
Groucho mediated repression could be identified. 
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Abstract 
 
 
 
 Two novel components of the Wingless signaling cascade in drosophila were recently 
identified in Drosophila, Pygopus and Legless (1, 2, 3, 4). Here we study the function of their 
mammalian homologs, hPYGOPUS-1, hPYGOPUS-2 and BCL-9.1 and BCL-9.2. We show that 
PYGOPUS-2 and BCL-9.2 show a ubiquitous expression pattern in a panel of cell lines, whereas 
PYGOPUS-1 and BCL-9.1 expression is more restricted. PYGOPUS and BCL-9 together enhance 
WNT signaling in a TCF reporter assay, only when the cascade is activated by WNT-1, not by any 
of the other stimuli tested, including co-transfection of β-catenin or dominant negative AXIN. 
Cellular localization studies suggest a role of BCL-9 in nuclear transport of β-catenin.  
 
 
 
 
Introduction 
 
 
 
WNT signaling controls multiple cell fate decisions in animal development (as reviewed in 
(5)), like embryonic segmentation, axis specification and the regulation of stem cell number and 
differentiation in epithelia, such as those of the skin and colon (6, 7). Initially the outline of this 
signaling route was identified in Drosophila genetic screens, but this pathway is conserved 
throughout the animal kingdom, from flies, worms, frogs, mice to man.  
 Activation of the WNT signaling pathway results in activation of downstream target genes, 
resulting in cell fate specification. Genetic and biochemical approaches have outlined the 
canonical WNT signaling pathway as we now know it (reviewed in (8)). At the heart of this 
cascade is the regulated stability of free, cytoplasmic β-catenin. In the absence of a WNT signal, 
β-catenin is targeted for degradation by the action of a multi-protein complex of glycogen 
synthase kinase 3β (GSK-3β), the scaffold protein Axin and the adenomatous polyposis coli 
(APC) tumour suppressor. This complex phosphorylates the N terminus of β-catenin and primes it 
for ubiquitination and subsequent degradation by the proteasome. When a WNT ligand binds to its 
receptors Frizzled and LRP, Dishevelled (DVL) inhibits the complex of Axin, APC and GSK-3 
from phosphorylating β-catenin, resulting in the accumulation and nuclear translocation of β-
catenin. In the nucleus, β-catenin binds the DNA binding factor TCF and this bi-partite 
transcription factor will activate target genes.  
Deregulation of the WNT signaling cascade is associated with carcinogenesis. 80 % of the 
sporadic and hereditary colorectal tumours show inactivation of APC (9). Mutated APC is no 
longer able to down regulate β-catenin, causing free β-catenin to accumulate, translocate to the 
nucleus and aberrantly activate target genes. Among the 20 % colon carcinomas that have wild-
type APC, about 5% have mutations in β-catenin (10). Typically, these mutations affect the GSK3 
phosphorylation sites rendering β-catenin insensitive to degradation. These β-catenin mutations 
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are also found in cancers of many other tissues, including melanomas, gastric cancer and hair 
follicle tumours (11, 12).  
 It is well established that the formation of the β-catenin-TCF complex is the prerequisite 
for the activation of target genes. Some questions however still remain to be answered. For 
example, we do not know how the localization of β-catenin is controlled, how translocation to the 
nucleus is regulated when the cell receives a WNT signal and how β-catenin activity is dampened 
when WNT signaling decreases. The mechanism of β-catenin nuclear import is largely unknown. 
It was shown to be independent of the importins, the classical NLS receptors, and possibly 
mediated by direct interaction with the nuclear pore complex (13, 14, 15). This was all shown in 
in vitro permeabilized cells. Possibly, in live cells other mechanisms are involved. There is 
evidence that β-catenin constantly shuttles between the nucleus and the cytoplasm. Its localization 
would be determined by competition between constant export mediated by APC (16, 17) and 
nuclear retention by binding to TCF. To address these and other yet unidentified aspects of the 
WNT signaling cascade, new protein interaction screens and genetic screens have been carried 
out.  
Pygopus (1, 2, 3, 4) and Legless (4) have recently been identified as two novel components 
of the Wingless (Wg) signaling pathway in Drosophila mutagenesis screens for dominant 
suppressors of Wg overactivation. Inactivation of these proteins rescues the phenotype that is 
caused by ectopic Wg signaling activation, either by ectopic expression of Wingless (1, 4, 3) or 
activated Armadillo (2). Both Pygopus and Legless mutant flies fail to transduce Wg signaling, as 
was shown by the loss of expression of Wingless target genes, like Distalless in the wing imaginal 
disk (2, 3, 4), Engrailed in the ventral epidermis (1), and labial in midgut development (1). This 
demonstrates that Pygopus and Legless are essential for Wingless signal transduction in vivo. No 
effects were observed on the expression levels of several EGF and Hedgehog target genes in 
Pygopus or Legless mutant flies (2, 4), indicating that these protein are dedicated to the WNT 
signaling cascade, nor were any changes in localization or levels of Armadillo protein expression 
observed in the Pygopus mutant flies, signifying that Pygopus is not implicated in stabilization or 
localization of Armadillo (2, 1). Genetic epistasis experiments show that these proteins function 
downstream of Axin (1, 3) and Shaggy/GSK3 (4) and even downstream of a constitutively active 
form of Armadillo (4). 
The Legless protein consists of 1464 amino acids and reportedly contains three homology 
domains, HD1, HD2 and HD3, of which the HD1 domain mediates binding to Pygopus and the 
HD2 domain is the interaction domain for β-catenin (4). Drosophila Pygopus is comprised of 815 
amino acids and contains two conserved domains, an N-terminal homology domain (NHD) and a 
PHD domain at the c-terminus, which mediates interaction with Legless (4). PHD domains are 
frequently found in proteins involved in chromatin remodelling (18, 19), which would hint at a 
possible function of Pygopus in β-catenin-Tcf mediated target gene activation, although also the 
PHD domains have also been described to function as a ubiquitine ligase or as a more general 
protein scaffold (20, 21). Both Legless (4) and Pygopus (3, 1) proteins show a nuclear localization 
upon over-expression in mammalian cells. The mammalian homolog of Legless BCL-9, 
PYGOPUS, β-catenin and TCF are found in one multi-protein complex in in vitro translation 
experiments. 
A model was proposed where Legless functions to bring Pygopus to Tcf-β-catenin 
complex and affect target gene expression. The role of these proteins in the mammalian system 
has hardly been addressed. Pygopus and Legless have two mammalian family members each. The 
role of these proteins in WNT signaling will be studied more closely in this chapter.  
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Materials and methods 
 
 
 
Cell lines and reagents 
For transfection experiments the human embryonic kidney cell line, 293T, was used. For the 
Northern blot the following human cell lines were used as a source of RNA: Jurkat (T cell line), 
XGL and RPMI (B cell lymphoma lines), 293T, HT29, LS174, SW480, HCT116, DLD-1, RKO 
and CaCO2 (colon carcinoma cell lines). HEK-TR cell line (Invitrogen) was used for the RNAi 
experiments. Cells were cultured in RPMI (Life technologies), supplemented with 5% fetal calf 
serum and antibiotics. 
 
Northern blot 
Northern blot was performed by standard procedures. RNA from cell lines was isolated using the 
Chomczynski and Sacchi procedure (22). For each sample 10 µg RNA was loaded on a 1.2% 
agarose gel containing 2% formaldehyde. RNA was transferred to Zeta-Probe membranes 
(Biorad). Loading was checked by ethidium bromide staining. Hybridization was performed using 
ExpressHyb Hybridization Solution (Clontech). Probes were labelled using the RadPrime DNA 
labelling system (Invitrogen) 
 
Transfections and Luciferase assays 
0.3 x 106 293T cells were transfected using fugene (Roche) according to manufacturer's 
instructions. Cells were transfected with various combinations of a luciferase reporter plasmid 
containing three optimal Tcf sites upstream of the minimal HSV-TK promoter (100 ng of pTK-
TOP) or its negative control vector containing mutated Tcf sites (pTK-FOP), an internal 
transfection control (50 ng of pRNL-TK, Promega) and one or more of the following expression 
constructs: hBCL-9.1; hPYGOPUS-2 expression vectors (50 ng -500 ng); WNT-1 expression 
plasmids (5 ng). The total amount of plasmid DNA transfected was made equivalent with 
pCDNA3. cDNAs encoding hBcl-9.1 and hPygopus2 (a kind gift from K. Basler) and their 
deletion mutants were expressed as Flag or Myc tagged versions in pCDNA3. Luciferase activities 
were determined 24 h after transfection using the DUAL luciferase system according to the 
manufacturer's protocol (Promega). Luciferase activity was normalised relative to RNL-luciferase 
activity. For every experiment transfections were performed in duplicate and several independent 
experiments were performed. 
 
Immunoprecipitation and Western blotting 
For immunoprecipitation experiments, 293T cells were co-transfected with Flag-hBCL-9.1-
pCDNA3, and Myc-hPygopus2-pCDNA3 or β-catenin-pCi. Cells were harvested and lysed on ice 
for 30 minutes in IP lysis buffer (50 mM Tris pH 7.8, 150 mM NaCl, 5mM MgCl2, 0.1% Non-
Idet-P40, 1mM dithiothreitol) containing protease inhibitors (Protease inhibitor cocktail tablets, 
Roche Diagnostics). After clearance the lysate was incubated overnight at 4oC with 5 µl Flag 
coupled beads (Sigma), or with 5 µl Myc coupled beads (Sigma), or with 4 µl anti-β-catenin 
antibody (Transduction Labs) and 5 µl protein A/G beads (Santa Cruz). Immunoprecipitates were 
washed once with lysis buffer and three times in wash buffer (20 mM Tris pH 7.8, 100 mM NaCl, 
1 mM EDTA and 0.1% Non-Idet-P40). Material bound to the beads was eluted in SDS-loading 
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buffer and resolved by SDS-PAGE gels, transferred on PVDF membrane (Biorad) The membrane 
was incubated with anti-Flag (Sigma), anti-Myc or anti-β-catenin antibodies and immune reactive 
proteins were visualised by enhanced chemiluminescence. (Amersham Pharmacia Biotech) 
 
Tandem affinity (TAP) procedure 
The TAP procedure was used to purify proteins associated with hPYGOPUS-2. For this use, a 
fusion protein was constructed between PYGOPUS-2 and the TAP tag at the c-terminus of the 
protein (the vector containing the TAP tag was kindly provided by Dr. J. van Es). 293T cells were 
transfected with this vector and harvested as described above. The vector only encoding the TAP 
tag was used as a negative control. The lysate was adjusted to IgG binding conditions (180 mM 
NaCl, 10 mM Tris pH 8, 0.2% NP-40 and 0.5 mM DTT). This was incubated over night at 0C 
with IgG beads (Amersham Bioscience) for 1st extraction of protein A binding proteins. IgG 
beads were washed twice with IgG binding buffer and once with TEV cleavage buffer (10 mM 
Tris pH 8, 150 mM NaCl, 0.3% NP-40, 0.5 mM EDTA, 0.5 mM DTT). The beads were 
resuspended in 1 ml TEV cleavage buffer and 150 U of TEV protease was added and incubated at 
16 0C, mixing regularly for 2 hrs. Supernatant was collected and adjusted to calmodulin binding 
conditions (45 mM Tris pH 8, 150 mM NaCl, 0.7 mM MgAc, 0.7 mM Imidazole, 2.5 mM CaCl2, 
0.2% NP-40, 10 mM β-mercapto-ethanol). 50 µl calmodulin affinity resin (Stratagene) was added 
and this was incubated for at least 2 hrs at 4oC. The protein complexes with beads were washed 
three times with calmodulin binding buffer, and separated on SDS-polyacrylamide gels. Proteins 
were detected by silver stain, specific bands were cut from the gel and analyzed by mass 
spectrometry. (J. Krijgsveld, Utrecht) 
 
RNAi studies 
The doxycyclin regulated vector pTER, as recently described by Van de Wetering et al (23) as 
used to knock down Pygopus2 gene expression. The oligonucleotides used were as follows: 
For oligo 5, 5'-
GATCCCTCCACCTGCTTCTACTGCTTTCAAGAGAAGCAGTAGAAGCAGGTGGATTTTT
GGAAA-3' and 5'-
AGCTTTTCCAAAAATCCACCTGCTTCTACTGCTTCTCTTGAAAGCAGTAGAAGCAGGT
GGAGG-3; for oligo 6, 5'-
GATCCCCGATGACCAGGATGCCATTTTCAAGAGAAATGGCATCCTGGTCATCGTTTTT
GGAAA-3' and 5'-
AGCTTTTCCAAAAACGATGACCAGGATGCCATTTCTCTTGAAAATTGGCATCCTGGTC
ATCGGG; for oligo7, 5'-
GATCCCGCTTCTGCCGTCTGGGCCTTTCAAGAGATGGCCCAGACGGCAGAAGCTTTTT
GGAAA-3' and 5'-
AGCTTTTCCAAAAAGCTTCTGCCGTCTGGGCCTTCTCTTGAATGGCCCAGACGGCAGA
AGCGG-3' 
The HEK-TR line from Invitrogen was used to generate pTER stable cell lines. This cell 
line expresses the Tet-repressor, that can be switched off upon treatment of the cells with 
doxycyclin. HEK-TR cells were transfected with the pTER-Pygopus2 oligo's and zeocin resistant 
clones were selected for their ability to down regulate PYGOPUS-2 by Northern blotting. 
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Immunofluorescence 
0.3 x 106 293T cells were grown on a glass cover slip and transfected using fugene (Roche) with 
various combinations of the following expression constructs: Flag-BCL-9, GFP-5'-BCL-9, VSV-
PYGOPUS, CFP-Pygopus, Myc-β-catenin. After 24 hours cells were fixed by adding 1/10 volume 
37% formaldehyde directly to the culture medium. After 5 minutes at room temperature, cells 
were washed in PBS and directly embedded in Vectashield (Vector Laboratories Inc.) or used for 
antibody staining. For primary antibody the mouse anti-Flag (Sigma) or anti-Myc (8E9, 
monoclonal cell line) monoclonal antibody were used, these were detected either with anti-mouse 
IgG-FITC or anti-mouse IgG-FITC (Southern Biotechnology Associated). 
 
 
 
 
 
Results  
 
 
 
In mammals two proteins were identified that share high homology with Drosophila 
Pygopus, hPYGOPUS-1 and hPYGOPUS-2. These proteins are smaller than Drosophila Pygopus, 
but they also have the conserved NHD and PHD domains (Figure 1A). BCL-9, the putative 
mammalian homologue of Drosophila Legless, is hardly conserved on overall amino acid 
sequence, but clearly the conserved homology domains HD1, HD2 and HD3 can be identified 
(Figure 1A).  
BCL-9 has initially been identified as the gene involved in the t(1;14) (q21;q32) 
translocation in the B cell lymphoma line CEMO (24). Chromosome 1q21-25 is one of the 
hotspots of chromosomal abnormalities including translocations and duplications in Non-
Hodgkin’s lymphoma and multiple myeloma. Rearrangements at this site are associated with 
tumour progression (reviewed in (25)). Nevertheless considerable promiscuity exists in the 
translocation partners with which 1q regions rearrange, BCL-9 is found in some cases, but also 
LHX4 (26), FCγRIIB (27), MUC1 (28) and IRTA1 and IRTA2 (29) are often found. This suggests 
that the deregulation of BCL-9 expression is probably not causing B cell lymphoma.  
The two protein families of BCL-9 and PYGOPUS have been conserved throughout 
vertebrate evolution, given that homologous proteins are found in mouse, rat and frog (Figure 1B). 
The conserved domains are almost identical between the family members of different species 
(figure 1C), both for the PYGOPUS NHD and PHD domains and the HD domains of BCL-9. 
Moreover two previously unidentified conserved domains were recognized in the C-terminus of 
the BCL-9 proteins, HD4 and HD5 (Figure 1C). 
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Figure 1. Domain structure of BCL-9 and PYGOPUS proteins. 
1A. Schematic representation of the BCL-9 protein with the conserved homology domains (HD) 1-5, and PYGOPUS 
with the N-terminal homology domain (NHD) and plant homology domain (PHD) 
1B. BCL-9 and PYGOPUS are conserved proteins throughout the animal kingdom, homologues have been identified 
in human (h), rat (r), mouse (m) and frog (x). 
1C. Alignment of the amino acid sequences of the conserved domains of BCL-9 and PYGOPUS proteins. 
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The expression patterns of PYGOPUS and BCL-9 were determined in a panel of human 
cell lines by Northern blot (Figure 2). Several colon carcinoma cell lines were tested (SW480, 
DLD-1, HT29, LS174, HCT116, RKO and CACO2), an embryonic kidney cell line (239T), a T 
cell line (Jurkat) and two B-cell lymphoma cell lines (XGL and RPMI). In colon carcinoma cell 
lines, the WNT signaling cascade is constitutively activated. In all but one of these (RKO) 
mutations in APC of β-catenin have been identified. Aberrant expression of PYGOPUS or BCL-9 
might account for the activation of the pathway in the RKO cell line. The B cell lymphoma cell 
lines were used to determine if these would show over-expression of the BCL-9, as has been 
described for the cell line CEMO (24). 
 Expression of PYGOPUS-1 was detected only in the cell lines HT29, 293T, Jurkat and 
XGL, whereas PYGOPUS-2 showed a more broad expression pattern, being present in all cell 
lines tested. BCL-9.1 also showed expression, though weak in all cell lines tested, except for 
HT29, 293T, Jurkat and XGL where it is highly expressed. BCL-9.2 is highly expressed in all cell 
lines from this panel. The levels of PYGOPUS and BCL-9 in RKO cell line is not different from 
the other cell lines, indicating that aberrant expression levels of PYGOPUS and BCL-9 are not 
implicated in the elevated WNT signaling activity in this cell line. The expression of BCL-9.2 in 
the RPMI cell line and BCL-9.1 and BCL-9.2 in the cell line RPMI, might be slightly increased, 
but is not strongly over expressed as described for the CEMO cell line (24), indicating that these 
two cell lines probably have no activated BCL-9 as a result from a translocation t(1;14) (q21;q32). 
 These data show that at least one member of the PYGOPUS and one BCL-9 family is 
expressed in every cell line.  
 
 
Figure 2A. The expression patterns of PYGOPUS-1, PYGOPUS-2, BCL-9.1 and BCL-9.2 in several human cell 
lines. Expression patterns were determined by Northern blot in a panel of human cell lines. SW480 (lane1), DLD-
1(lane 2), HT29 (lane 3), LS147 (lane 4), HTC116 (lane 5), RKO (lane 6), CACO2 (lane7), 293T (lane 8), Jurkat 
(lane 9), XGL (lane 10), RPMI (lane 11).  
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Cell line SW480 DLD1 HT29 LS174 HTC116 RKO  CACO2 293T Jurkat XGL RPMI
PYGOPUS1 +/- - + - - - - + +/- +/- +/- 
PYGOPUS2 + + + + + + + + + ++ ++ 
BCL9.1 +/- +/- + +/- +/- +/- +/- + + ++ +/- 
BCL9.2 ++ ++ ++ ++ ++ + ++ + + +++ ++++ 
 
 
Table 1. The expression of PYGOPUS-1, PYGOPUS-2, BCL-9.1 and BCL-9.2, is tabulated for the different cell 
lines.  - , no visible signal, +/- weak signal, + signal, ++++ strong signal 
 
 
 To determine the role of PYGOPUS and BCL-9 in the mammalian WNT signaling 
cascade, the effect of over-expression of these proteins was determined in a β-catenin-TCF 
reporter gene assay (30). In this assay, transfection of Wnt-1 in 293T cells activates the WNT 
signaling pathway, resulting in transactivation of a luciferase reporter gene containing a promoter 
with optimal TCF sites (TOP-TK). As a negative control a luciferase reporter is used with mutated 
TCF sites (FOP-TK), which is not sensitive to activation of the WNT signaling cascade. Co-
transfection of different amounts and combinations of expression constructs for PYGOPUS-2 and 
BCL-9.1 were used to determine the effect of these proteins on Wnt-1 mediated activation (Figure 
3A.).  
Transfection of PYGPOPUS alone does not affect WNT signaling. Upon transfection of 
BCL-9, only a marginal, 2 fold increase in TCF signaling is observed. Co-transfection of both 
PYGOPUS and BCL-9 results in an enhancement of WNT signaling of about 5-10 times. This 
was shown to be concentration dependent and specific for TOP-TK, since no effect was observed 
on FOP-TK. 
The WNT signaling pathway in these 293T cells was activated in several ways, to 
determine where in the cascade PYGOPUS and BCL-9 exert their function. Activation of the 
cascade was carefully optimized to about 5-10 fold, ensuring that it still is possible to enhance the 
transactivation, since WNT signaling in 293T cells can be activated at least 50 fold with mutant β-
catenin (data not shown). In figure 3B, WNT signaling was stimulated by addition of LiCl or by 
transfection of either wild-type or mutant β-catenin, lacking the S33 phosphorylation site 
rendering the protein insensitive to degradation. Activation of the cascade by these stimuli could 
not be enhanced by the combination of PYGOPUS and BCL-9, in contrast to the published (4) 
enhancement of stabilized β-catenin signaling by PYGOPUS alone. No enhancement by 
PYGOPUS and BCL-9 was detected when the cascade was activated by a dominant negative 
version of β-TRCP or a dominant negative version AXIN, or by DISHEVELLED (figure 3C), nor 
was any effect observed of BCL-9 and PYGOPUS single or co-transfection in colon carcinoma 
cell lines (data not shown). WNT signaling in these cell lines is constitutively activated as a 
consequence of β-catenin or APC mutation, but apparently PYGOPUS and BCL-9 can not 
enhance this any further.  
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These data show that BCL-9 and PYGOPUS can enhance β-catenin-TCF mediated 
signaling, but only when activation of the cascade is initiated by Wnt-1. Data from Drosophila 
show that Pygopus and Legless are genetically downstream of Axin, GSK-3β and stabilized 
Armadillo. This apparent discrepancy may reflect over-expression of BCL-9 and PYGOPUS in 
the TCF reporter assays as described here versus the inactivation of either protein in the 
Drosophila system. 
 
 
Figure 3. BCL-9 and PYGOPUS together enhance TCF mediated WNT signaling 
239T cells were transfected with the TCF reporter construct (containing either wild type TCF binding sites, TOP-TK, 
or mutated TCF binding sites, FOP-TK, as a negative control), Renilla luciferase as a transfection efficiency control, 
WNT-1 and several combinations of BCL-9 and PYGOPUS expression constructs. 
3A. Only co-transfection of PYGOPUS with BCL-9 enhances TCF signaling when the cascade is activated by Wnt-1 
(5 ng) 
3B. PYGOPUS and BCL-9 do not enhance TCF mediated transactivation when the cascade is activated with 15 mM 
LiCl or upon co-transfection with wild type β-catenin (400 ng) or mutated S33-β-CATENIN (25 ng) 
3C. PYGOPUS and BCL-9 do not enhance TCF mediated transactivation when the cascade is activated with a 
dominant negative version of β-TRCP, dominant positive AXIN, or DISHEVELLED 
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To determine if the interactions for the Drosophila proteins also are found for human 
PYGOPUS and BCL-9, immunoprecipitation experiments were carried out. 293T cells transiently 
transfected with expression constructs for Flag-BCL9.1 and Myc-PYGOPUS-2. Cell lysates were 
immunoprecipitated with Myc-antibody coupled directly to sepharose beads and the presence of 
BCL-9 was assayed in Western blot using a the Flag antibody (Figure 4A). To exclude aspecific 
binding of Flag-BCL-9 to the beads, a negative control was included with lysates of cells only 
transfected with Flag-BCL-9 that were also immunoprecipitated with Myc-coupled beads. The 
Flag-BCL9 protein is readily expressed, when the whole cell lysate (WCL) is analyzed on 
Western blot. Flag-BCL-9 is also immunoprecipitated efficiently with Flag antibody. Only when 
Myc-Pygopus is co-transfected Flag-BCL-9 is present in the Myc immunoprecipitate.  
Similar results are obtained in the reverse experiment, when Flag-BCL-9 is 
immunoprecipitated and the presence of Myc-PYGOPUS is assayed (Figure 5B). The molecular 
weight of Myc-PYGOPUS is about 50 kDa. A biotinilated anti-Myc antibody was used in the 
Western blot to prevent the rabbit-anti-mouse-HRP secondary antibody crossreacting with the 
immunoglobulin heavy chain from the antibody used in the immunoprecipitation. This was 
detected with streptavidin-coupled HRP, that does not cross react with the immunoglobulin. The 
Myc-PYGOPUS is expressed (WCL) and immunoprecipitated efficiently (IP a-Myc), and only 
upon presence of Flag-BCL-9 is Myc-PYGOPUS present in the immunoprecipitate using the Flag 
antibody (Figure 4B). 
 The interaction between BCL-9 and β-catenin was addressed by immunoprecipitation. 
Cells were transfected with Flag-BCL-9 with or without β-catenin, and lysates were precipitated 
with Flag coupled beads. The precipitate was analyzed by Western blot (figure 4C). β-catenin is 
efficiently expressed (WCL), and immunoprecipitated (IP anti-β-catenin) and only when Flag-
BCL-9 is present, β-catenin is present in the Flag-precipitation. Similar results were obtained 
when the reversed experiment was carried out. Lysates from cells with β-catenin with or without 
Flag-BCL-9 were used for immunoprecipitation with β-catenin antibody. 
 
 
 
 
Figure 4. BCL-9 interacts with PYGOPUS and β-catenin. 
Flag-BCL-9 and Myc-PYGOPUS (4A and 4B) or Flag-BCL-9 with Myc-β-catenin (4C) are co-transfected in 293T 
cells, 24 hours after transfection cells are harvested and lysed. Protein complexes were immunoprecipitated using 
anti-Flag or anti-Myc coupled beads and analyzed by Western blot (WB) of total expressed protein (WCL) and 
immunoprecipitated (IP) protein. 
4A. Flag-BCL-9 and Myc-PYGOPUS co-immunoprecipitation with Myc antibody. 
4B. Myc-PYGOPUS and Flag-BCL-9 co-immunoprecipitation with Flag antibody. 
4C. Flag-BCL-9 and β-catenin, co-immunoprecipitation with Flag antibody. 
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Studies from Pygopus mutants in Drosophila (4, 2) show that both the PHD domain and 
the NHD domains of Drosophila Pygopus are essential for its function. The PHD domain is used 
for interaction with BCL-9 but the function of the NHD is unknown. We used the Tandem 
Affinity Purification (TAP) procedure to identify novel PYGOPUS interacting proteins (31, 32). 
This procedure is a tool to allow rapid purification of protein complexes under native conditions. 
The TAP-tag consists of two immunoglobulin-binding domains of protein A from Staphylococcus 
aureus, a cleavage site for the tobacco etch virus (TEV) protease, and the calmodulin binding 
peptide. Protein purification is achieved via two step affinity chromatography, carried out under 
native conditions. The TAP tag is fused to the protein of interest and expressed, the fusion protein 
and associated proteins are recovered from cell extracts by affinity selection on an IgG matrix. 
After washing, the TEV protease is added to release bound material. This leaves a bulk of non-
specifically associated proteins on the beads, resulting in much less background compared with 
conventional precipitation methods. The eluate is incubated with calmodulin coated beads for a 
second affinity purification step and after washing the bound material can be eluted with EGTA. 
The TAP tag was fused to the c-terminus of PYGOPUS-2. 293T cells were either stably or 
transiently transfected with this expression construct, cells were lysed in TX100-lysis buffer and 
TAP-PYGOPUS was purified from the extract using the described procedure. After binding to the 
calmodulin column the protein complexes were not eluted with EGTA, since this did not result in 
a very efficient recovery. Protein complexes on the calmodulin beads were directly eluted in SDS 
loading buffer and resolved on SDS-polyacrylamide gel and silver stained (Figure 5). No obvious 
difference was observed between the pattern of bands of associated proteins in the extracts from 
stably transfected or transiently transfected protein. 
From several experiments bands of associated proteins were cut from silver stained gel and 
analyzed by mass spectrometry. Proteins identified using this procedure were the uncleaved 
Pygopus-TAP protein, often HSP70-1,-5,-8 were identified, but also BCL-9 was recovered from 
the precipitate (Figure 6). The presence of heat shock proteins is probably caused by the over-
expression of TAP-PYGOPUS. Several different buffers were used for the preparation of the 
extract, also TAP-PYGOPUS was stably transfected into LS174 cell line and purified from these 
cell extracts, but no associated proteins other than heat shock proteins were identified, BCL-9 was 
not found in these purifications. Upon co-transfection of Wnt-1 with TAP-PYGOPUS, BCL-9 is 
still found associated with PYGOPUS, but no novel associated proteins were identified, as far as 
detectable on silver stain gel. 
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Figure 5. Purification of PYGOPUS associated proteins using the TAP procedure. 
293T cells were transiently transfected with an expression vector for the TAP-PYGOPUS fusion protein (B) or the 
TAP expression vector alone as negative control (A). Protein complexes were isolated, purified and separated on 
denaturing protein gel and stained using silver stain. Specific bands of interacting proteins were cut from gel and 
analyzed by mass spectrometry. 
 
 
 
To determine if PYGOPUS really is essential for WNT signaling, we used RNAi to 
inducibly knock down the protein in mammalian cells. For this we used RNAi oligo’s expressed 
by the pTER system as recently described by Van de Wetering et al (23). The pTER vector 
contains Tet repressor sites between the Histone H1 promoter and the RNAi sequences. In cell 
lines expressing the Tet repressor protein, it will bind to its target sites inserted in the H1 
promoter, resulting in a block of transcription. The cell lines used here express the tetracycline 
repressor under the control of doxycyclin: in absence of doxycycline, binding of the Tet repressor 
blocks the H1 promoter, and addition of doxycycline inhibits the binding of the Tet repressor to 
the H1 promoter, releasing transcription of the RNAi sequences.  
The human embryo carcinoma cell line that expresses the Tet repressor under the control 
of doxycycline (HEK-TR) was used for the RNAi experiments to knock down PYGOPUS. This 
cell line was used because PYGOPUS and BCL-9 enhance TCF signaling in the related 293T cell 
line and not in the colon carcinoma cell lines with a constitutively activated WNT signaling 
pathway.  
Seven RNAi oligo’s for PYGOPUS-2 were developed and cloned into the pTER vector. 
The effectivity of these oligo’s was first tested on transiently transfected Flag-PYGOPUS-2 in 
293T cells. Cells were transiently transfected with 100 ng Flag-PYGOPUS and 1 µg of the RNAi 
oligo. After one, two and three days cells were harvested, lysed in TX100 lysis buffer and the 
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amount of Flag-PYGPOUS was determined by western blot, after correction for total amount of 
protein by Bradford. 
Only three oligo’s worked in this assay (Figure 6). One day after transfection no effect of 
the oligo’s is visible, but after 2, and most obvious after 3 days the amount of PYGOPUS protein 
is strongly down regulated.  
 
 
 
 
 
Figure 6. RNAi vectors for PYGOPUS-2 efficiently knock down transiently transfected protein. 
293T cells were transfected with 100 ng Flag-tagged PYGOPUS-2 and 1 µg of either of the PYGOPUS-2 RNAi 
vector in pTER, 5, 6 or 7. Cells were harvested after 2 and 3 days of transfection. Flag-PYGOPUS-2 levels were 
determined on denaturing polyacrylamide, after correction for total protein amount with Bradford. 
 
 
 
The RNAi oligo’s 5, 6 and 7 were used to make stable transfectants in the HEK-TR cell 
line. Clones were selected that down regulate the PYGOPUS mRNA after induction with 
doxycyclin. Three clones were selected and induced with doxycycline for three days (Figure 7). 
Down-regulation of the PYGOPUS-2 mRNA is clearly observed in the lines with oligo 6 and 7, 
the line with oligo 5 only gives a moderate reduction of mRNA levels. Induction does not show 
any affect on the HEK-TR cell line.  
 
 
  
 
Figure 7. Stably integrated RNAi vectors for PYGOPUS-2 knock down the endogenous mRNA of PYGOPUS-2 
in the HEK TR cell line 
HEK-TR cells were stably transfected with three different RNAi oligo's in pTER, 5, 6 and 7. Cells were seeded and 
induced with doxycycline for a time course of three days. Each day cells were harvested, RNA was isolated and 
analyzed by Northern Blot. Ethidium bromide staining served as a loading control. 
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 To determine if the down-regulation of PYGOPUS-2 in the HEK TR cell line has an affect 
on WNT signaling, the TOP/FOP reporter assay was used. The PYGOPUS RNAi cell lines were 
seeded and doxycyclin was added, after 1,2 and 3 days these were transfected with the TCF 
reporter (TK-TOP) or its negative control (TK-FOP) with or without WNT-1. As a negative 
control, cells were transfected similarly, but not induced with doxycycline. Also the HEK-TR cell 
line was included to exclude any non-specific effects (Figure 8). One day after transfection cells 
were lysed and luciferase activity was measured. Transfection of Wnt-1 in the PYGOPUS RNAi 
cell lines does result in an increase of β-catenin-TCF mediated transcriptional activation. Addition 
of doxycycline and subsequent down-regulation of the PYGOPUS mRNA however, has no effect 
on this WNT-1 mediated transcriptional activation. This could be caused by the fact that the 
PYGOPUS-2 mRNA is not completely down regulated after 3 days of induction (Figure 8). 
Moreover, PYGOPUS-1 still present in these cell lines, could be sufficient to maintain TCF 
signaling. Currently RNAi oligo’s for PYGOPUS-1 are transfected in these cell lines in an attempt 
to down regulate both PYGOPUS messages and to be able to observe an effect on WNT signaling. 
 
 
 
 
Figure 8. Effect of knock down of PYGOPUS-2 on TCF mediated signaling 
HEK-TR cells were stably transfected with the pTER vectors encoding RNAi oligo's for PYGOPUS-2. Cells were 
seeded and induced with doxycycline. After 1, 2 or 3 days of induction these were transfected with the Tcf reporter 
(TK-TOP) or its negative control (TK-FOP) with or without Wnt-1. One day after transfection cell were harvested and 
luciferase levels were determined. Three different cell lines were tested, each expressing a different RNAi oligo for 
Pygopus-2, panel A. cell line 5; panel B. cell line 6 and panel C. cell line 7. The parental cell line was used as a 
negative control, panel D. HEK-TR. 
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 The cellular localization of PYGOPUS and BCL-9 was studied using immunofluorescence 
on fixed cells transfected with expression constructs of BCL-9, PYGOPUS or β-catenin. Initially, 
Flag-BCL-9 and VSV-tagged PYGOPUS were detected using the Flag or VSV antibody and 
visualized with a secondary antibody labelled with FITC or TRITC. Later also fusion proteins 
were constructed with green fluorescent protein (GFP) or cyan fluorescent protein (CFP) 
 Localization of GFP-BCL-9 was hard to visualize, since this protein appeared to 
accumulate in strongly fluorescent dots. To circumvent this problem we used a fusion between 
GFP and a N terminal part of BCL-9 comprising of amino acid 1 to 582, still containing the HD1, 
HD2 and HD3 domains (GFP-5' BCL-9). This truncated version of BCL-9 however, does not 
enhance WNT-1 mediated TCF signaling as determined by the TOP/FOP reporter assay (Figure 
12). Apparently for full function of BCL-9 also the HD4 and HD5 domains are indispensable. 
This GFP-5'-BCL-9 showed a similar distribution to Full length Flag-BCL-9. We are currently 
repeating the localization experiments of co-transfection of Flag-BCL-9 with CFP-β-catenin. 
 Flag-5'-BCL-9 localization showed three types of localization in 293T cells, in about 30% 
of the cells BCL-9 is exclusively cytoplasmic, in 50% of the cells the protein is homogeneously 
distributed between cytoplasm and nucleus, while in 20% of the cells show BCL-9 localization in 
the nucleus (Figure 9A). This is in contrast with the previously described nuclear localization of 
BCL-9 in the wing blade primordium (4). When the β-catenin interaction domain HD2 is deleted 
from this BCL-9 construct, the localization of the protein shifts to a total nuclear localization 
(Figure 9B). This effect is not caused by lack of the HD4 and HD5 domains, since deletion of 
HD1 or HD3 of GFP-5' BCL-9 results in a distribution similar to wild type GFP-5'-BCL-9 (as 
summarized in Table 3). The nuclear localization of the deletion mutant lacking the HD2 domain, 
therefore must be caused by the deletion of its β-catenin interaction domain. Apparently, BCL-9 
localization is affected by β-catenin or conversely, β-catenin localization may be affected by BCL-
9, or both.  
 PYGOPUS is localized in the nucleus, as observed when VSV-PYGOPUS is transfected in 
293T cells and detected with anti-VSV and a secondary antibody labelled with TRITC (Figure 
9C.), similar to the localization of CFP-PYGOPUS (data not shown). Transfection of Myc-β-
catenin and subsequent detection with anti-Myc and TRITC shows that the protein is evenly 
distributed between the nucleus and the cytoplasm. (Figure 9D.)  
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Figure 9. Localization of BCL-9, PYGOPUS and β-catenin in transiently transfected 393T cells. 
9A. Distribution of GFP-5'-BCL-9 in different cells. About 20% of the cells show an exclusive cytoplasmic 
localization, in 50% the protein is homogeneous distributed between the cytoplasm and the nucleus, and 30% of the 
cells show an exclusive nuclear BCL-9 localization. 
9B. Deletion of the β-catenin interaction domain HD2 form BCL-9 results in exclusive nuclear localization of the 
protein 
9C. VSV-PYGOPUS localization is determined by staining with anti-VSV antibody and a TRITC labelled second 
antibody. The protein is exclusively present in the nucleus. 
9D. Myc-β-catenin is distributed evenly between cytoplasm and nucleus. the protein was detected with anti-Myc 
antibody and a TRITC labelled second antibody. 
 
 
 
 When CFP-PYGOPUS and GFP-5'-BCL are co-transfected, a complete co-localization is 
observed, both proteins now reside in the nucleus (Figure 10.) 
 
 
 
Figure 10. Co-localization in the nucleus of GFP-5'-BCL-9 and CFP-PYGOPUS 
293T cells were co-transfected with GFP-5'-BCL-9 and CFP-PYGOPUS and harvested after 24 hours. Localization of 
both proteins was determined by immunofluorescent mircoscopy  
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 The nuclear localization of BCL-9 lacking the β-catenin interaction domain, ∆HD2-BCL-
9, prompts the question if the localization of BCL-9 and β-catenin are inter-dependent. To address 
this, Myc-β-catenin and GFP-5'-BCL-9 were co-transfected and the localization of both proteins 
was determined using direct fluorescence for BCL-9 and anti-Myc combined with a secondary 
TRITC labelled antibody for Myc-β-catenin (Figure 11). A clear co-localization is observed for 
both proteins, either in the nucleus or homogeneously distributed throughout the cell. The number 
of cells with nuclear BCL-9 staining is increased when co-transfected with β-catenin from 30% to 
65%.  
 
 
 
Figure 11. Co-transfection of GFP-5'-BCL-9 and Myc-β-catenin  
293T cell were transfected with GFP-5'-BCL-9 and Myc-β-catenin, fixed after 24 hours and stained with anti-Myc 
antibody. This resulted in total co-localization of both proteins, either nuclear (65 %) or homogeneous distributed 
(35%). 
 
 
 
 This could indicate that BCL-9 can induce β-catenin translocation to the nucleus, 
suggesting a role for BCL-9 in β-catenin nuclear in- or export. One hypothesis could be that the 
HD2 domain of BCL-9 is a nuclear export signal, which is masked upon β-catenin binding, 
resulting in nuclear accumulation of BCL-9. In this model, BCL-9 would shuttle between 
cytoplasm and nucleus, and upon β-catenin binding BCL-9 would still translocate to the nucleus 
co-transporting β-catenin. Some similarities exist between the HD2 sequence and a classical NES. 
In this model localization of BCL-9 would then be affected by Leptomycin B (LMB), an inhibitor 
of the CRM1 mediated nuclear export machinery (33). However, when cells were transfected with 
GFP-5'-BCL-9 and treated with LMB, only a marginal increase in nuclear localization of BCL-9 
was observed of maximum 1.5 - 2 fold. Moreover, when the HD2 domain is fused to GFP, it is 
distributed homogeneously over nucleus and cytoplasm and this does not change upon treatment 
with LMB. This indicates that the classical CRM1 nuclear export pathway does not play a major 
role in the localization of BCL-9. Nuclear export mechanisms exist that are insensitive to LMB, so 
the hypothesis that HD2 domain functions as a nuclear export signal can not be excluded.  
 Another experiment was designed to address the relation between β-catenin and BCL-9 
localization. A colon carcinoma cell line (SW480) is used in which β-catenin can be inducibly 
knocked down, as recently described in Van de Wetering et al. (23). In this cell line, induction 
with doxycycline results in transcription of RNAi oligo's for β-catenin and subsequent knock 
down of β-catenin expression. These cells were transfected with GFP-5' BCL-9 and treated with 
doxycyclin. After three days, the localization of BCL-9 was determined. As a negative control, the 
same procedure was carried out with the SW480-TR cell line, lacking the RNAi oligo's (Table 2). 
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 When the RNAi for β-catenin is induced, the number of cells with nuclear BCL-9 staining 
decreases from 30% to 13%. This effect is not observed in the cell line that does not contain the 
RNAi oligo's. 
 
 
 
 Induction of β-catenin 
RNAi 
% cells with 
nuclear BCL-9 
% cells with 
homogenous BCL-9 
SW480-TR - 19 81 
 + 17 83 
SW480-TR with RNAi - 30 70 
oligo's for β-catenin + 13 97 
 
 
Table 2. Effect of β-catenin knock down on BCL-9 localization 
Two cell lines, SW480-TR and SW480-TR with RNAi oligo's for β-catenin, were transfected with GFP-5'-BCL-9 and 
treated with doxycycline. BCL-9 localization was determined three days after transfection. (This experiment is one 
representative of four different experiments that were performed) 
 
 
 
 Deletion mutants for HD1, HD2 and HD3 were used to study the role of these domains in 
the function of BCL-9. These deletion mutants were constructed from full length BCL-9 as well as 
from the GFP-5'-BCL-9. Again, expression in 293T cells of the full length versions of ∆HD1, 
∆HD2 and ∆HD3 show strong accumulation in highly fluorescent dots, which is impossible to 
visualize. Truncated variants of ∆HD2 and ∆HD3 give a clear fluorescence, hence these were used 
for the following experiments. The localization of these proteins upon transfection in 293T cells 
was determined, with and without co-transfection of PYGOPUS or β-catenin (Table 3). Moreover, 
the long versions of these full length deletion mutants were also tested in the TCF reporter assay 
to determine the effect on the signaling capacities of these BCL-9 mutants (Figure 12).  
 The localization pattern of BCL-9 lacking its PYGOPUS interaction domain (∆HD1) is 
similar to wild type BCL-9, indicating that the nuclear localization we observe with 20% of the 
cells is not caused by interaction with PYGOPUS. As expected the localization of ∆HD1-BCL-9 
is insensitive to co-transfection with PYGOPUS and still sensitive to co-transfection with β-
catenin, an increase from 17% to 69% is observed in the number of cells with nuclear BCL-9. 
 The cellular distribution of the deletion mutant lacking the β-catenin interaction domain, 
∆HD2, is somewhat more puzzling. Its localization shifts almost entirely to the nucleus as we have 
observed previously. Also upon co-transfection with PYGOPUS the protein localizes to the 
nucleus, as expected. Co-transfection with β-catenin results in a localization pattern similar to the 
wild type BCL-9, not to an increase in nuclear localization since this mutant lacks its β-catenin 
interaction domain. 
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 The HD3 domain contains a putative nuclear localization signal (NLS) (Figure 1). Deletion 
of this domain was predicted to affect the localization of BCL-9 and have an effect on its signaling 
capacities. Unexpectedly, the ∆HD3 mutant stills shows nuclear localization in 16 % of the cells, 
apparently the HD3 domain does not contain a functional NLS Also this protein is sensitive to co-
transfection with PYGOPUS, resulting in a nuclear localization, from 16 % to 96 % of the cells 
now showing nuclear localization. Also co-transfection of β-catenin results in a shift towards more 
nuclear localization, but with an attenuated effect, from 16 % to 58 %. 
 
 
 
 
 
  % cells nuclear BCL-9 
staining 
% cells homogenous or 
cytoplasmic staining BCL-9 
BCL-9 - 23 78 
 + PYGOPUS 97 3 
 + β-catenin 65 35 
∆HD1-BCL-9 - 17 83 
 + PYGOPUS 4 96 
 + β-catenin 69 31 
∆HD2-BCL-9 - 84 16 
 + PYGOPUS 94 6 
 + β-catenin 66 34 
∆-HD3-BCL-9 - 16 84 
 + PYGOPUS 96 4 
 + β-catenin 58 42 
 
 
Table 3. Localization of deletion mutants of GFP-5'-BCL-9 
293T cell were transfected with 500 ng of either of the GFP-tagged deletion constructs of BCL-9, ∆HD1, ∆HD2, and 
∆HD3 in combination with pCDNA3 (empty vector), with Myc-PYGOPUS-2, or with β-catenin. 24 hours after 
transfection cells were fixed and the localization of BCL-9 was determined.  
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 When these deletion mutants are tested in a TCF reporter assay, it is clear that only the 
wild type BCL-9 protein and the ∆HD3 mutant are still capable of enhancing the Wnt-1 induced 
signaling (Figure 12). As expected, since both interaction with PYGOPUS and β-catenin are 
essential for proper function of BCL-9 as has been shown in literature. 
 
 
 
 
Figure 12. Effect of ∆HD1-, ∆HD2- and ∆HD3-BCL-9 with PYGOPUS on Wnt-1 activation  
293T cells were transfected with the Tcf reporter (TK-TOP) or its negative control (TK-FOP) with 5 ng WNT-1 and 
500 ng PYGOPUS-2 and 150 ng of wild type Flag-BCL-9, ∆HD1, ∆HD2, ∆HD3-BCL-9-EGFP, full length EGFP-
BCL-9 or EGFP-5'-BCL-9. 
 
 
 
 
 
Discussion 
 
 
 We have shown that PYGOPUS and BCL-9 are broadly expressed in the mammalian 
system. They play a role in transduction of a WNT signal, as PYGOPUS and BCL-9 together 
enhance TCF mediated transactivation when the cascade is activated with WNT-1. The 
interactions reported for the Drosophila system are present in mammalian cells. PYGOPUS and 
BCL-9 bind to each other and BCL-9 also interacts with β-catenin. Over-expression of β-catenin 
and PYGOPUS re-locates BCL-9 from the cytoplasm to the nucleus, and down-regulation of β-
catenin releases BCL-9 from the nucleus. The data obtained so far clearly point in the direction of 
BCL-9 affecting the localization of β-catenin, but not the transcriptional activity of β-catenin-TCF 
as has been proposed in literature (4, 2, 1, 3). The role of PYGOPUS is still unclear. It could 
function as an anchor for BCL-9 to enable β-catenin release to TCF, but also a direct role on 
transcriptional activation via BCL-9 and β-catenin interaction as proposed cannot be excluded. 
 Many questions on BCL-9 and PYGOPUS function remain unanswered. Using the TCF 
reporter assay and over-expression of the proteins, it cannot clearly be addressed where in the 
cascade these proteins exert their function. Identifying novel binding partners of these proteins 
might shed more light on this matter. Currently, we are involved in high throughput yeast two 
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hybrid screens, with both PYGOPUS and BCL-9 proteins. In the lab, mass spectrometry analysis 
on protein complexes from large scale purification of protein complexes using 
immunoprecipitation with a Flag antibody has proven to be quite successful. This method as well 
as the TAP affinity purification as described above can also be used to identify BCL-9 interaction 
partners. 
 A way to study the mechanism of this nuclear translocation more closely would be to use 
photo bleaching techniques together with the fluorescent labelled proteins. This way the effect of 
several proteins on nuclear import rate of β-catenin can be measured, like co-transfection with 
WNT, PYGOPUS or BCL-9. 
 To determine the role of these proteins in vivo, the generation of monoclonal antibodies 
will be very important. These can be used in several experimental procedures. For example, they 
can be used to identify binding partners of BCL-9 and PYGOPUS in studies without over-
expression systems, or they can be used to determine the expression patterns and localization of 
these proteins in tissues where WNT signaling is activated, for example in crypts of the small 
intestine, versus the expression in tissues where there is no WNT signaling, like in the villi of the 
small intestine. This could provide evidence if the localization and possibly transport of BCL-9 
and β-catenin also play a role in vivo.  
 Much information in PYGOPUS and BCL-9 function in the mammalian system will be 
gathered by determining the effect on WNT signal transduction in the absence of these proteins. 
Generating inducible knock-out mice for these proteins is elaborate work since both proteins have 
two mammalian homologs. RNAi technology to knock down PYGOPUS and BCL-9 expression is 
another way to study the effect of BCL-9 and PYGOPUS depletion on WNT signaling. So far, 
only inducible cell lines were generated in which the PYGOPUS-2 mRNA did not decrease very 
strongly. Possibly, efficient down-regulation of proteins by RNAi requires the effect of several 
RNAi oligo's. In the above described cell lines additional different oligo's for PYGOPUS-2 can be 
transfected to mediate a stronger down-regulation of the PYGOPUS-2 mRNA. Subsequent 
introduction of RNAi oligo's for PYGOPUS-1 in the same cell line would result in a cell line in 
which all Pygopus mRNA can be efficiently down modulated. The effect of depletion of 
PYGOPUS on WNT signal transduction could then be addressed in these cell lines. The same 
approach is currently used to make cell lines in which both BCL-9.1 and BCL-9.2 can be 
efficiently knocked down. This way also the effect of down modulation of BCL-9 on WNT signal 
transduction will be determined.  
 Future research will unravel the mechanism by which BCL-9 and PYGOPUS function in 
WNT signaling. This may very well be an essential role, in accordance with the data from 
Drosophila. If PYGOPUS and BCL-9 function are absolutely required and specific for WNT 
signal transduction, this would make these proteins and possibly their interaction partners suitable 
targets for drug development. More than > 85 % of the sporadic and hereditary colorectal tumours 
show aberrant activation of the WNT signaling cascade. If disruption of the β-catenin-BCL-9 
interaction would inhibit WNT signal transduction, for example by blocking the nuclear 
translocation of BCL-9, then small molecular compounds might be designed to inhibit the 
interaction between BCL-9 and β-catenin. However, these would need to be very specific in 
blocking only this interaction, since β-catenin binding to E-cadherin should not be affected. Also 
PYGOPUS might be a target for small molecule inhibitors, especially if future research shows that 
this protein functions exclusively in WNT signaling. Possibly, elucidation of the mechanism by 
which PYGOPUS and BCL-9 function and the identification of their binding partners might 
provide insights to design novel drug targets. 
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Regulation of TCF transcriptional activity, repression, 
activation and fine-tuning 
 
 
The WNT signaling pathway plays a decisive role during embryonic patterning and cell 
fate determination during development (as reviewed in (1)). This signaling cascade is highly 
conserved throughout evolution. Indeed, orthologs of proteins that are involved in WNT signaling 
are found in many species ranging from fruit flies to man. The key effector of the canonical WNT 
pathway is the multi-functional and proto-oncogene β-catenin (2).  
If the WNT pathway is not activated, free β-catenin is actively targeted for degradation in 
the cytoplasm by the so-called destruction complex. This multiprotein destruction complex 
contains the serine/threonine kinase GSK-3β, casein kinase CK1, the scaffold protein Axin and the 
tumour suppressor protein APC (reviewed in (3)). The destruction complex phosphorylates β-
catenin, thereby priming it for ubiquitination and subsequent degradation by the proteasome. As a 
consequence, levels of free β-catenin in the cell remain low. Meanwhile in the nucleus, TCF 
transcription factors are associated with transcriptional repressors including members of the 
Groucho (Grg) family (4, 5, 6). This interaction leads to the active repression of TCF target genes. 
Upon activation of the WNT pathway, a cascade of events is relayed that destabilizes the 
destruction complex, allowing unphosphorylated β-catenin to accumulate and to translocate to the 
nucleus. Once in the nucleus, β-catenin associates with a member of the Tcf family. This 
interaction converts TCF from a transcriptional repressor into transcriptional activator (7, 8). This 
bipartite protein complex activates transcription of WNT target genes such as c-Myc (9), EphB2 
(10) and c-Myb (10).  
 
 
 
Repression 
 
 In absence of a WNT signal, TCF confer target gene expression by its association with 
transcriptional co-repressors: CtBP (11) and/or Groucho (4, 5, 6). In Drosophila, CtBP is 
characterized to mediate short range repression, whereas Groucho mediates long range repression 
(12, 13, 14). Furthermore, CtBP only interacts with some TCF splice variants (Tcf-3 and Tcf-4E) 
(11). This suggests multiple mechanism of regulation through repression. Drosophila Groucho is 
the founding member of family of transcriptional co-repressors. The mouse genome contains four 
Groucho-related-genes (Grg 1-4) and a truncated variant (Grg-5). Grg proteins contain 5 protein 
domains. The amino-terminal tetramerization domain, the Q (glutamine rich) domain, followed by 
a GP (glycine/proline rich) domain, a CCN (containing putative casein kinaseII/cdc2 
phosphorylation sites and a nuclear localization signal), a SP (serine/proline rich) domain and four 
WD repeats (protein interaction domains). Grg-5 only consists of the two most N-terminal 
domains of the Grg proteins, the Q and GP domain. Grgs bind to histone de-acetylases (HDAC) 
which confer repression by de-acetylation of the N-terminal tails of core histones, hereby 
condensing local chromatin structure (15). 
 In Chapter 2 we described the results of the study on the specificity of the interaction 
between the TCFs and individual members of Grg family. This was carried out in a functional 
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assay combined with careful documentation of the expression pattern. In addition, the role of Grg-
5 was studied in more detail. 
 Using the TCF reporter assay we showed that transcriptional activation of each of the TCF 
family members can be repressed by each of the ‘long’ Grg proteins, Grg-1-4 (16). This indicates 
a functional interaction between all TCF and Grg family members. However, it shows no 
specificity in the interaction between the members of these two protein families. The TCFs and 
the human Groucho homologs (TLE’s) show a broad expression pattern in cell lines. Several Grgs 
and TCFs are co-expressed in every cell line, as well as in different mouse tissues (Chapter 2 and 
3). This shows that there is no unique combination of individual TCF and Grg family members 
based on their expression in cell lines. The abundance of the Grg proteins and the redundancy with 
which they interact with Tcf proteins, probably highlights the requirement to silence target gene 
expression adequately. This is essential in order to prevent unrestrained cell growth and/or 
aberrant differentiation. Indeed, deregulation of the Wnt pathway may cause cancer (reviewed in 
(2)).  
The functional interaction between TCF and Grg-5 was studied in TCF reporter assays 
(Chapter 2). Grg-5 acts as a de-repressor of TCF transcriptional activity. Upon transfection of 
TCF and β-catenin, activity of a reporter is enhanced by adding Grg-5. Grg-5 can still interact 
with the “long” versions of the Grg family members through the Q domain (17). The de-repressive 
function of this protein was clarified by immune precipitation experiments studying interactions 
with HDAC. Grg-5 has lost the capacity to bind to the histone de-acetylase 1 (HDAC-1), whereas 
a truncated version of Grg-4, containing only the Q and GP domain, does still interact with 
HDAC-1. From this data the following model emerges, where Grg-5 is a natural inhibitor of Grg 
mediated repression. When Grg-5 associates with other Grg family members, the amount of 
HDAC tethered to the template is decreased, reducing the level of repression. 
Another level of regulation of repression of target genes is conferred by the expression of 
different TCF splice variants. Several naturally occurring splice variants of the different TCF 
family members have been described, one of these lack the N-terminal part of the protein which 
encodes the β-catenin interaction domain (18), so called ∆N variants. These are no longer able to 
bind to β-catenin, but can interact with Groucho proteins. The ∆N-TCF proteins block 
transcriptional activation in colon carcinoma cell lines (19, 10). Since Grg proteins are abundantly 
expressed, these ∆N-Tcf variants do not only block activation by competing with endogenous 
TCF-β-catenin complexes, but probably even function as active transcriptional repressors.  
 Several questions regarding Grg mediated repression of TCF target genes however, still 
remain unanswered. The mechanism of Grg mediated repression is not entirely clear yet. Although 
it is well known that Grg proteins interact with histone deacetylase proteins (HDAC), Grg 
mediated repression is only partially dependent on interaction with HDAC. Inhibition of HDAC 
function by Trichostatin A (TSA) e.g. results only in a partial relieve of repression (15) Moreover, 
an additional repression domain, although less potent, has been identified in the WD40 repeat 
domains of the Grgs (20). These data suggest that Grgs may also utilize histone deacetylase-
independent mechanisms for transcriptional repression. Possibly the generated and extensively 
characterized monoclonal antibodies described in Chapter 3 can be used to purify protein 
complexes and to identify other proteins associated with Grg repressors, elucidating the HDAC 
independent repression mechanism. 
In addition, it is not clear how the transition is achieved from TCF as a repressor, in 
complex with Grg proteins, to an activator upon association with β-catenin. The β-catenin and Grg 
interaction domains do not overlap in the Tcf protein sequence. So far, it has not been addressed if 
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these two proteins can simultaneously bind to TCF. Grg proteins are large proteins and they 
function as tetramers. Association of a large Grg complex with TCF might make it structurally 
impossible for β-catenin to bind this complex at the same time. Moreover, it is thus far unknown if 
accumulation of β-catenin is enough to convert Tcf from a transcriptional repressor into a 
transcriptional activator. Perhaps an additional modification (e.g. phosphorylation) of Grgs is 
required. 
Since Grg proteins are transcriptional co-repressors for many DNA binding factors, it still 
has to be clarified how the correct distribution is achieved amongst the many interaction partners. 
Several reports indicate that there might be non-redundant functions for the different Grg protein 
family members (21, 22). Clearly, not all regulation mechanisms of Grg function have been 
uncovered yet and await further analysis. This will undoubtedly be helped by new technologies, 
including genomics and proteomics. 
 
 
 
Activation 
 
 Upon activation of the Wnt signaling cascade, β-catenin accumulates and translocates into 
the nucleus. The mechanism of nuclear import is still unknown. It is clear that the nuclear import 
of β-catenin is independent of transport factors like importins or Ran GTP (23). It has been 
suggested that β-catenin directly interacts with the nuclear pore as a possible mechanism to enter 
the nucleus (24, 25). 
 In the nucleus, TCF and β-catenin bind and from a bi-partite transcription factor. The C-
terminus of β-catenin contains a transactivation domain, while Tcf is able to bind to DNA. This 
interaction results in the activation of TCF target gene expression. Interactions with additional 
proteins activate β-catenin/Tcf activity. These proteins include the TBP, CREB and Brg. More 
specifically, β-catenin can bind to the TATA binding protein TBP, either directly (26) or via 
Pontin 52 (27), recruiting proteins of the general transcription machinery. In addition, the CREB 
binding proteins (CBP) can bind to β-catenin and enhance transcriptional activation via its histone 
acetylation activity (HAT) (28, 29). This results in a de-condensed chromatin structure which 
increases the accessibility of other transcription factors to target gene promoters (30, 31). Another 
β-catenin interacting protein is Brg, a component of the SWI/SNF chromatin remodelling complex 
(32). β-catenin could, therefore, be viewed as a docking molecule that recruits essential co-
activators to target gene promoters. These interaction of β-catenin and a co-activator might be 
specific for a certain set of promoters.  
 Recently, two novel nuclear components of the Wnt signaling cascade were identified in 
Drosophila, Pygopus and Legless (33, 34, 35, 36). Mutant flies for Legless or Pygopus have a 
phenotype similar to Wingless mutant, indicating that they are essential for Wg signaling. A direct 
interaction was observed between Legless and Pygopus, as well as between Legless and 
Armadillo, the Drosophila homolog of β-catenin. Pygopus contains a PHD domain, a motif often 
found in chromatin remodelling factors. A model was proposed in which Pygopus and Legless are 
implicated in the transcriptional activation of TCF target genes (33, 34, 35, 36).  
Pygopus and Legless are the founding members of two protein families that have been 
conserved from flies to man. The mammalian genome encodes two homologs of Legless (BCL-9) 
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and two PYGOPUS proteins. We studied the role of PYGOPUS and BCL9 in the mammalian Wnt 
signaling cascade. These experiments are described in Chapter 4. 
 PYGOPUS-2 and BCL-9.2 show an ubiquitous expression pattern in a panel of cell lines, 
whereas PYGOPUS-1 and BCL-9.1 expression is more restricted. PYGOPUS and BCL-9 together 
enhance WNT signaling in a TCF reporter assay, only when the cascade is activated by WNT-1, 
not by any of the other stimuli tested. Cellular localization studies suggest a role of BCL-9 in 
nuclear transport of β-catenin.  
Comparing these results with the published data from Drosophila leads to some intriguing 
differences. In Drosophila Legless and Pygopus are downstream of activated Armadillo, as was 
shown by epistasis experiments using flies mutant for these proteins. In our TCF reporter assays, 
we only observe an enhancing effect of BCL-9 and PYGOPUS when the WNT signaling cascade 
is activated with Wnt-1, activation by any other stimulus is unaffected (e.g. β-catenin, LiCl or 
dominant negative Axin). This difference may be explained by the difference in species studied. 
Furthermore, we used over-expression of BCL-9 and PYGOPUS in cell lines, whereas in 
Drosophila experiments the result of the absence of both proteins was studied.  
Other captivating aspects emerge from this study. Co-transfection of β-catenin with BCL-9 
results in enhanced nuclear accumulation of both proteins, but no effect on TCF transcriptional 
activation is observed in our reporter assay. Apparently, increased nuclear localization of β-
catenin by BCL-9 is not enough to enhance TCF transcriptional activation. Perhaps additional 
cofactors are limiting and/or lacking.  
Another question is raised by the activation of the cascade in colon carcinoma cell lines. In 
these cells β-catenin is not degraded, due to mutations in APC or β-catenin. As a result, the WNT 
signaling cascade is constitutively activated. However, there is no evidence for up-regulation of 
BCL-9 and/or PYGOPUS. Are these proteins not limiting in these conditions, do they not function 
down stream of AXIN or GSK3β, or are they not essential for WNT signal transduction in the 
mammalian system at all?  
 Further research will unravel the intriguing role of BCL9 and PYGOPUS in WNT 
signaling. This will be carried out by using protein interaction screens to identify which proteins 
are involved in nuclear import of β-catenin, antibodies to elucidate the in vivo localization of 
BCL-9 and β-catenin and knock down in cell lines and mouse knock out models.  
 
 
 
Concluding remarks 
 
 The highly regulated WNT signaling cascade plays a decisive role during embryonic 
patterning and cell-fate determination. The inappropriate expression of WNT target genes, 
resulting from deregulation of this pathway, is also implicated in tumorigenesis. Thus, regulation 
of this pathway is of paramount importance. The transcriptional status of WNT target genes is not 
merely determined by a binary code of activation or repression by TCF transcription factors, but is 
subject to many subtle levels of regulation. Additional factors, such as ∆N-TCF splice variants, 
Grg-5 proteins natural inhibitors of Grg function and promotor specific β-catenin interacting co-
activators, will ultimately determine the transcriptional state of a specific WNT target gene. 
Understanding this complexity of Wnt signaling regulation is just beginning to be elucidated. The 
study described in this thesis adds a small but significant step. 
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Een organisme bestaat uit verschillende weefsels, die opgebouwd zijn uit cellen. Cellen 
zijn dus de bouwblokken van elk levend organisme. De ontwikkeling van slechts een cel naar een 
heel organisme is een zeer complex en nauwkeurig gereguleerd proces. Hierbij is het belangrijk 
dat de juiste cellen zich op het juiste moment ontwikkelen tot een celtype met een bepaald functie, 
zoals botcellen of spiercellen. Dit proces van specialiseren noemen we differentiatie. Een 
volwassen organisme heeft cellen die een heel leven meegaan en niet opnieuw kunnen worden 
gemaakt, zoals zenuwcellen en hersencellen. Er zijn echter ook cellen die een relatief korte 
levensduur hebben en dus steeds opnieuw aangemaakt moeten worden, zoals bloedcellen, 
huidcellen en darmcellen. Ook dit is een zeer gecontroleerd proces). De celtypes die steeds 
opnieuw worden aangemaakt, hebben ‘moeder’cellen ofwel stamcellen, die steeds opnieuw delen, 
maar zelf niet specialiseren. Slechts de dochtercel differentieert zich tot een cel met een specifieke 
functie. De stamcellen zijn een continue productiebron van een bepaald type cellen. Zo zijn er 
onder andere stamcellen te vinden in de darm, in het bloed en in de huid. 
Eiwitten zijn de structurele bouwstenen van de cel en tevens de uitvoerders bij 
verschillende processen, zoals de energiehuishouding en celtype specifieke functies zoals 
voedselopname en -verwerking in de darm en zuurstoftransport door het bloed. De informatie 
voor de productie van de eiwitten ligt in het DNA, in de genen. Genen zijn stukjes DNA die 
expliciet voor één eiwit coderen. Iedere cel bevat exact hetzelfde DNA, maar niet alle DNA wordt 
vertaald naar eiwit. Verschillende celtypen hebben verschillende functies en gebruiken dan ook 
verschillende combinaties van eiwitten. 
Het onderzoek beschreven in dit proefschrift heeft de regulatie van WNT signalering 
bestudeerd. De WNT cascade is een van de signaleringsroutes die het proces van delen en 
specialiseren in goede banen moeten leiden. Een signaleringsroute is een soort door-geef-systeem 
in een cel, waarbij de cel signalen uit zijn omgeving ontvangt die hem vertellen wat hij moet gaan 
doen, delen of specialiseren en hoe. Een signaal komt aan bij de cel en wordt herkend aan het 
oppervlak van deze cel. Daarmee wordt een proces in de cel in werking gezet waarbij het signaal 
in verschillende stappen wordt doorgegeven naar de celkern, de uitvoerende afdeling van de cel. 
In de kern wordt het signaal gelezen en de cel ontwikkelt zich in de richting die hem door deze 
boodschap verteld wordt. 
Dit proces van WNT signalering gebeurt door middel van eiwitten. Een eiwit, WNT, komt 
aan bij een cel, bindt aan zijn ontvanger-eiwit aan de buitenkant van de cel en via aan aantal 
eiwitten in de cel, wordt dit het signaal doorgegeven aan de celkern. In de celkern wordt het 
signaal ontvangen en vertaald, wat leidt tot de productie van een bepaalde set van eiwitten die 
essentieel zijn voor de verdere ontwikkeling van dit celtype. Het aanschakelen van de productie 
van eiwitten gebeurt door zogenaamde transcriptiefactoren. Transcriptiefactoren zijn als het ware 
de machientjes die het DNA van genen lezen en de productie van eiwit in gang zetten. Als er dus 
een WNT signaal van het celoppervlak door de cel naar de celkern wordt doorgegeven, leidt dit 
uiteindelijk tot de activatie van deze transcriptiefactor die op hun beurt een programma aanzetten 
dat leidt tot de productie van specifieke eiwitsets. In het geval van activatie van de WNT 
signaleringscascade wordt een transcriptiefactor aangezet die is opgebouwd uit twee eiwitten, 
namelijk TCF en β-catenine (zie figuur 1). 
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Figuur 1. Een schematisch overzicht van de WNT signaleringscascade. 
In afwezigheid van een WNT signaal wordt β-catenine afgebroken in het cytoplasma. Wanneer een WNT eiwit de cel 
bereikt wordt de signaleringscascade geactiveerd. β-catenine wordt niet langer afgebroken en gaat naar de celkern. In 
de celkern bind β-catenine aan TCF en samen zetten zij de productie van specifieke eiwitsets aan. 
 
 
 
Het is belangrijk dat de WNT signaleringsroute alleen in heel specifieke omstandigheden 
geactiveerd wordt. Dit mag namelijk alleen in de zogenaamde stamcellen die slecht delen en niet 
specialiseren zodat het een continue bron van nieuwe dochtercellen is. Als de WNT 
signaleringsroute onverhoopt toch aan komt te staan in een ander celtype, dan zal dit daar ook 
leiden tot voortdurende celdeling, wat kan leiden tot kanker. Dit kan gebeuren door een mutatie in 
het DNA waarbij de transcriptiefactor al in zijn actieve staat geproduceerd wordt, zodat er geen 
signaal van buiten de cel nodig is om dit hele proces aan te zetten. Het is gebleken dat een 
ontregelde controle over deze signaleringsroute de oorzaak is van meer dan 90 % van de 
darmkanker in de westerse wereld. Ook speelt deze ontregeling een rol bij huidkanker en bij 
bepaalde soorten leverkanker. Een beter begrip van deze signaleringsroute zal ons dus meer 
inzicht geven in het ontstaan van deze soorten kanker en kan mogelijk op de lange termijn leiden 
tot een medicijn.  
 Wanneer ontregeling van deze signaleringsroute zulke dramatische effecten heeft en 
wanneer deze route alleen aan staat in een specifiek soort cellen, dan moet de negatieve regulatie, 
de manier waarop wordt verzekerd dat deze route UIT staat, wel heel goed gewaarborgd zijn. In 
cellen die geen WNT signaal ontvangen, is op een aantal manieren verzekerd dat de 
signaleringsroute niet spontaan geactiveerd wordt. Een van de manieren om dit te bereiken is door 
de transcriptiefactor β-catenine erg instabiel te maken. Deze wordt namelijk direct nadat hij is 
aangemaakt meteen weer afgebroken. Alleen wanneer een WNT signaal de cel activeert wordt β-
catenine niet langer afgebroken, gaat naar de celkern en bindt daar aan TCF zodat de productie 
van eiwitten kan beginnen. Ook is er in de kern een negatieve controle waarbij TCF gebonden 
wordt door het Grg eiwit, zodat TCF niet actief is. 
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In de eerste twee experimentele hoofdstukken van dit boekje wordt de rol van deze 
remmers ofwel repressoren, de Grg eiwitten, nader bestudeerd. In zoogdiercellen bestaan vijf Grg 
genen die erg veel op elkaar lijken, zogenaamde Grg familieleden, Grg-1, Grg-2, Grg-3, Grg-4 en 
Grg-5. Zo ook voor de TCF genen, die een deel zijn van de transcriptiefactoren die geactiveerd 
wordt als de signaleringsroute ‘aan’ staat. Van deze TCF eiwitten zijn er ook vier: TCF-1, LEF, 
TCF-3 en TCF-4.  
In het tweede hoofdstuk hebben we bestudeerd of alle TCF familieleden kunnen binden 
aan en geremd kunnen worden door ieder Grg eiwit, of dat er misschien alleen bepaalde 
combinaties van een TCF met een Grg leiden tot remming. Dit hebben we bestudeerd door cellen 
verschillende combinaties van TCF en Grg eiwitten te laten produceren en dan de activiteit van 
TCF te meten. Hieruit bleek dat alle Grg eiwitten de activiteit van ieder TCF eiwit kunnen 
remmen. We hebben ook bestudeerd welke van de TCF en Grg eiwitten voorkomen in 
verschillende celtypen. Een aantal humane cellijnen werd getest op de aanwezigheid van ieder van 
de Grg en TCF familieleden. Hieruit bleek dat binnen een cel minstens drie, soms zelfs vier van de 
Grg en TCF eiwitten aanwezig waren. Dit geeft ook aan dat de negatieve regulatie van de 
activiteit van de TCF eiwitten erg belangrijk is. Van het Grg-5 eiwit was reeds bekend dat een 
stuk kleiner is dan de andere Grg familieleden. Het was niet duidelijk of dit eiwit nog dezelfde 
functie had als de andere Grgs. Wij laten zien dat Grg-5 eiwit functioneert als een anti-repressor, 
dat wil zeggen dat het wel aan TCF eiwitten kan binden, maar dat het geen remmende activiteit 
heeft. Wanneer Grg-5 bindt aan een TCF eiwit, dan kunnen de grote familieleden, de repressoren, 
niet meer binden, en dus niet meer remmen, vandaar de naam anti-repressor voor het Grg-5 eiwit. 
 In het derde hoofdstuk maken we antilichamen tegen de verschillende Grg eiwitten. 
Antilichamen zijn een soort vlaggetjes waarmee de aanwezigheid van een bepaald eiwit 
aangetoond kan worden. Met antilichamen die specifiek een van de Grg eiwitten herkennen, 
wilden we de aanwezigheid van de verschillende Grg eiwitten in muizenweefsels bestuderen. Na 
het vrij langdurige proces van het maken van deze antilichamen, werden deze in verschillende 
types experimenten getest op hun specificiteit. Dit wil zeggen dat het antilichaam tegen Grg-1 
alleen Grg-1 mag herkennen en geen van de overige familieleden, hoewel deze eiwitten wel heel 
erg op elkaar lijken. Hieruit bleek dat we vijf zeer specifieke antilichamen in handen hadden, 
specifiek voor Grg-1, Grg-2, Grg-3, Grg-4 en Gg-5. Daarna hebben we deze antilichamen getest in 
een heel ander experiment, namelijk in het kleuren van muizenweefsels om de aanwezigheden van 
de verschillende Grg eiwitten aan te tonen. Slechts een van de vijf antichamen bleek functioneel te 
zijn in dit type experiment, namelijk het antilichaam tegen Grg-3. De weefselkleuringen laten zien 
dat het Grg-3 eiwit in bijna alle weefsels aanwezig is. Dit komt overeen met de resultaten uit het 
tweede hoofdstuk, waarin Grg-3 ook aanwezig is in alle humane cellijnen die we getest hebben. 
De hier ontwikkelde antilichamen tegen de Grg eiwitten zouden verder wellicht ook in andere 
experimenten gebruikt kunnen worden, zoals in biochemische studies om te bestuderen hoe deze 
eiwitten mechanistisch functioneren. Dit soort experimenten is echter niet uitgevoerd omdat ze 
buiten de doelstellingen van dit project vallen.  
 In het vierde hoofdstuk beschrijven we de studie naar twee eiwitten, waarvan pas zeer 
recentelijk duidelijk werd dat ze een rol spelen in de WNT signalering. Zoals gezegd speelt WNT 
signalering een belangrijke rol bij de balans van celdeling en differentiatie van cellen, zowel in 
volwassen organismen als in het zich ontwikkelende embryo. Gebleken is dat deze route zeer 
geconserveerd is gebleven in de evolutie. Dit wil zeggen dat de eiwitten die een rol spelen bij het 
doorgeven van het WNT signaal bij allerlei organismen voorkomen, bij mens en muis, maar ook 
bij kikkers en fruitvliegen. In eerste instantie is de WNT signaleringsroute zelfs ontdekt door 
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onderzoek dat werd gedaan naar de ontwikkeling van de fruitvlieg. Zo werden ook deze twee 
nieuwe eiwitten, Pygopus en Legless, voor het eerst geïdentificeerd in de fruitvlieg. Het was al 
snel duidelijk dat er ook zeer nauw verwante eiwitten bestaan in het zoogdiersysteem, maar hun 
exacte functie is nog onduidelijk.  
Bij zoogdieren zijn er twee eiwitten nauw verwant aan Pygopus van de fruitvlieg, deze zijn 
PYGOPUS-1 en PYGOPUS-2 genoemd. Ook zijn er twee eiwitten die lijken op het Legless bij 
fruitvliegen, die reeds eerder ontdekt waren bij ander onderzoek en BCL-9.1 en BCL9.2 heten. In 
het vierde hoofdstuk hebben we bestudeerd of deze PYGOPUS en BCL-9 eiwitten een rol spelen 
bij de WNT signaleringscascade. In eerste instantie hebben we bepaald of deze eiwitten een direct 
effect hebben op de activiteit van de transcriptiefactor TCF-β-catenine, maar dat bleek niet zo te 
zijn. Alleen wanneer deze signaleringsroute wordt geactiveerd door het WNT signaal zelf, neemt 
deze activatie toe wanneer extra BCL-9 gecombineerd met PYGOPUS wordt toegevoegd. Hieruit 
is nog niet duidelijk wat deze eiwitten nu precies voor functie hebben. Dit lijkt ook in contrast te 
staan met de resultaten van experimenten bij fruitvliegen, waaruit een rol voor deze eiwitten in de 
celkern en wel een direct effect op de transcriptiefactor TCF-β-catenine lijkt te blijken. Wanneer 
wij de lokalisatie van deze eiwitten bekijken in zoogdiercellen, dan zien we dat PYGOPUS in de 
celkern zit, maar dat BCL-9 in het cytoplasma aanwezig is. (het cytoplasma is het deel van de cel 
tussen celkern en celmembraan) En zodra wij PYGOPUS en BCL-9 samen door een cel 
geproduceerd laten worden, zien we dat nu beide eiwitten zich in de celkern bevinden en dat BCL-
9 niet meer in het cytoplasma aanwezig is. Ook als we BCL-9 met β-catenine samen bekijken zien 
we dat deze eiwitten samen een voorkeur hebben voor de celkern. Dit suggereert een rol voor 
BCL-9 en PYGOPUS in het transport van β-catenine naar de kern. Het exacte mechanisme 
waardoor β-catenine naar de kern gaat na een WNT signaal is nog niet opgehelderd, en vormt dus 
een interessant onderwerp voor nadere studie. De rol van BCL-9 en PYGOPUS in de WNT 
signaleringsroute zal onder andere met antilichamen en meer lokalisatie-experimenten ontrafeld 
kunnen worden. 
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